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This work covers research carried out over an 11-year period (2009 – 2020), during which 
my skills have developed. The research is in trigeminal-mediated headshaking, a 
neuropathic facial pain condition in horses.  
I have an international reputation in this field. I was awarded Fellowship of the Royal College 
of Veterinary Surgeons for Meritorious Contribution to Clinical Practice, largely due to my 
work in headshaking. 
I am submitting seven publications, five first and two last author, for incorporation into a 
thesis for a PhD by publication. Five papers have been published in Equine Veterinary 
Journal, the highest impact factor equine veterinary journal. Three have been given awards, 
as a result of which they have been circulated widely. One received a further award for being 
in the top 10% of downloaded papers from that journal in 2019. The last author publications 
were designed by me and I sourced funding and ethics approval for them. The first authors 
were postgraduate students conducting their first pieces of original research and therefore 
required close supervision. 
Chapter One reviews current understanding of trigeminal-mediated headshaking in the 
horse.  
Chapter Two: Prevalence. One aspect of the impact of a condition is its prevalence. There 
was no robust research into the prevalence of trigeminal-mediated headshaking in any 
country. A questionnaire study of horse owners determined prevalence of headshaking to be 
4.6% in the UK. 
Ross SE, Murray JK, Roberts VLH (2018) ‘Prevalence of headshaking within the equine 
population in the UK’ Equine Vet J. Jan;50(1):73-7. 
Chapter Three: Pathology. A translational study was performed to determine whether 
horses with trigeminal-mediated headshaking had focal demyelination of the trigeminal root 
as do a majority of sufferers of human trigeminal neuralgia, a clinically similar syndrome. No 
demyelination, and indeed no other gross pathology, was detected. This, alongside other 
factors, suggests that TMH is a functional rather than structural condition, which could 
therefore be reversible.  
Roberts VLH, Fews D, McNamara J, Love S. (2017) Trigeminal nerve root demyelination 






section Veterinary Neurology and Neurosurgery. May 15;4:72.doi:10.3389/fvets.2017.00072. 
eCollection 2017. 
Chapter Four: Diagnosis. Diagnosis of trigeminal-mediated headshaking is particularly 
challenging as it is one of exclusion. A useful step can be to demonstrate, using diagnostic 
local anaesthesia, that headshaking clinical signs are due to facial pain. A significant effect 
of operator experience on the accuracy, and therefore reliability, of this technique was 
determined.  
Wilmink S, Warren-Smith CM, Roberts VL.H (2015) Validation of the accuracy of needle 
placement as used in diagnostic local analgesia of the maxillary nerve for investigation of 
trigeminally mediated headshaking in horses. Vet Rec. Feb 7;176(6):148. 
Chapter Five: Treatment I. Neurectomy of the infra-orbital nerve has previously been 
reported as a possible treatment for trigeminal-mediated headshaking but success rates 
were low, and side-effects could be severe. A modified technique of infraorbital nerve 
ablation to increase success rates and reduce side-effects was investigated. Whilst this was 
achieved, only modest success rates were achieved and side effects could still be severe in 
some cases.  
Roberts V.L.H., McKane S.A., Williams A. and Knottenbelt D.C. (2009) Caudal compression 
of the infraorbital nerve: a novel surgical technique for treatment of idiopathic headshaking 
and assessment of its efficacy in 24 horses. Equine Vet J. 41(2): 165-7 
Roberts V.L.H., Perkins J.D., Skärlina E., Gorvy D.A., Tremaine W.H., Williams A., McKane 
S.A., White I. And Knottenbelt D.C. (2013) Caudal anaesthesia of the infraorbital nerve for 
diagnosis of idiopathic headshaking and caudal compression of the infraorbital nerve for its 
treatment, in 58 horses. Equine Vet J. Jan:45(1):107-10 
Chapter Six: Treatment II. Development and validation of a more effective and safer 
translational treatment based on a minimally-invasive therapy for people suffering 
neuropathic pain. A pilot study was later expanded to a larger international, multi-centre 
study.  
Roberts V.L.H., Patel N.K., Tremaine W.H. (2016) Neuromodulation using percutaneous 
electrical nerve stimulation for the management of trigeminal-mediated headshaking: A safe 







Roberts VLH, Bailey M, The EquiPENS™ Group, Patel N.K. (2020) Safety and efficacy of 
EquiPENS™ neuromodulation for the management of trigeminal mediated headshaking in 
168 horses. Equine Vet J. Mar;52(2):238-243. 
Chapter Seven discusses how my research skills have progressed and consider my 
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Review of trigeminal-mediated headshaking in horses 
1.1 Objectives of the thesis 
This thesis draws together my original research work in equine trigeminal-mediated 
headshaking. It encompasses a research journey furthering the understanding of trigeminal-
mediated headshaking. The research investigates the prevalence of this condition and then 
explores the aetiopathogenesis. This is followed by work to improve diagnosis and finally, 
utilising information gleaned earlier, studies to improve its management. Alongside this 
journey is my own personal research journey which will be considered in the Discussion.  
1.2 Clinical signs of trigeminal-mediated headshaking 
Occasional shaking of the head is normal equine behaviour. However, where the 
headshaking is any or all of: frequent; violent; characterised by flicks and jerks of the head; 
accompanied by signs of nasal irritation such as snorting, sneezing, rubbing the nose, 
striking the nose; accompanied by signs of distress or affects riding or handling the horse, 
then a pathological process must be considered (Pickles, 2014). Conditions which can cause 
headshaking may include: ear mite infestation, otitis interna, cranial nerve dysfunction, 
cervical injury, ocular disease, guttural pouch mycosis, dental periapical osteitis (Lane and 
Mair, 1987), protozoal myeloencephalitis (Moore et al, 1997) and sinusitis (Fiske-Jackson et 
al, 2012) as well as a behavioural or rider issue (Pickles, 2014).  However, where shaking 
was such that referral veterinary advice was required, there was a 98% chance that no 
physical cause could be determined, leading to a diagnosis of idiopathic headshaking (Lane 
and Mair, 1987). As knowledge of this condition has developed, it is likely that most of these 
horses were suffering what is now termed trigeminal-mediated headshaking (Pickles et al, 
2014). 
Clinical signs of trigeminal-mediated headshaking are usually of predominantly vertical 
headshaking, which may be violent (Pickles, 2014). These movements are often 
accompanied by sharp vertical flicks and signs of nasal irritation (Lane and Mair, 1987). 
Typically, signs are worst at exercise (Lane and Mair, 1987; Newton et al, 2000; Madigan 
and Bell, 2001), with only some horses being also affected at rest. Seasonality of clinical 
signs is reported in approximately 60% of headshaking horses, with the majority of these 
being documented as Spring/Summer affected (Madigan and Bell, 2001; Mills et al 2002). 
However, research included in this thesis found that horses were seasonally completely free 






2020, Paper 7). Even in non-seasonally affected horses, signs may vary with an apparent 
correlation to weather conditions (Lane and Mair, 1987; Madigan and Bell, 2001; Mills et al 
2002). 
1.3 Prevalence 
Knowledge of the prevalence of headshaking in the worldwide population is fundamental to 
understanding the scale of the welfare issue caused by trigeminal-mediated headshaking. 
Whilst there are reports of horses with signs consistent with trigeminal-mediated 
headshaking from many developed countries, only the UK horse population has been 
investigated in prevalence studies to date. There may be a complex interaction with 
environment in this acquired condition of unknown aetiology. For this reason, further 
information as to whether there is a difference in prevalence between countries, and in 
particular between developed and developing countries, would be of interest. 
The prevalence of headshaking in the UK equine population was first reported by Slater et al 
in 2013 as part of a general equine health survey. The prevalence of horses reported by 
their owners to have shaken their heads more than normal on a particular day of the year 
was reported to be between 1 and 1.5%. A dedicated study into the prevalence of 
headshaking in the UK equine population was published in 2018 (Ross et al, 2018), which is 
the subject of Chapter Two. Owners reported that 4.6% of their horses had shaken their 
heads more than normal in the last year, which increased to 6.2% if any time-point since 
ownership was considered. However, veterinary advice was sought in only 30% of these 
horses. This suggests that medically significant headshaking can be expected to affect 
around 2% of UK horses. Assuming an approximate UK horse population of one million 
(BETA, 2015), some 20,000 UK horses could be suffering from neuropathic facial pain. 
The study by Ross et al. (2018) found the median age of a horse with excessive 
headshaking to be 12 years but did not identify any association with sex or breed. Other 
studies have reported that the condition usually first affects adult horses in the prime of their 
lives, with median ages of onset varying from 6 years (Mills et al, 2002) to 10 years (Mair, 
1999). Geldings appear to be over-represented in some studies, comprising 63% (Mills et al, 
2002) to 71.5% (Madigan and Bell, 2001) cases but geldings are generally over-represented 
in a riding horse population (Aune et al, 2020). All breeds appear susceptible (Mills et al, 
2002 and Ross et al, 2018). There are no longitudinal studies following disease progression. 
There is a suggestion that some cases will progress in severity and from seasonal to non-
seasonal (Pickles et al, 2014). There is a suggestion that 5% of horses may enter 






Whilst trigeminal neuropathy is recognised in small animals (Mayhew et al, 2002), there 
appears to be limited clinical overlap with equine trigeminal-mediated headshaking. To the 
author’s knowledge there are only isolated anecdotal reports of clinical signs consistent with 
trigeminal-mediated headshaking, without investigation, in zebra and donkeys (personal 
observation). In the developed world this may be that other Equidae are not used for riding in 
any significant number and clinical signs are often only displayed during forced exercise. 
There may be further potential to explore why horses might be affected but other Equidae 
are not, or rarely so, as this could potentially give some information as to aetiology. Within 
the Equidae, discovering differences between horses in developed and developing countries 
and wild populations may help inform about influence of environment and management. 
1.4  Impact 
Disease impact encompasses morbidity, mortality and economic burden (WHO, 2018). For 
trigeminal-mediated headshaking this requires consideration of welfare and economic effects 
of the condition on the individual horse, the individual owner and the equine industry as a 
whole. The potential for translational research should also be considered. 
Horses suffering trigeminal-mediated headshaking are considered to have a neuropathic 
facial pain condition, and presence of pain has a negative impact on welfare. The degree of 
this negative impact can arguably be assumed to correlate with severity of pain. Human 
patients with neuropathic pain may report signs varying from tingling up to unbearable 
electric shock like pain, with quality of life significantly reduced (Dobrota et al, 2014). 
Severity of clinical signs in horses is likely to be our best indicator of their level of pain and 
severity of headshaking signs commonly varies between, and within, individuals. A variety of 
grading systems have been used to quantify severity of headshaking signs (Newton et al, 
2000; Talbot et al, 2013; Roberts 2014). The system used by Talbot focuses mostly on the 
effect of signs on the horse’s behaviour, that by Roberts on the utility of the horse to the 
owner and that by Newton is a combination (Table 1). An agreed methodology would be 
useful for more accurate monitoring of disease progression, treatment efficacy and 
comparison of published studies (Pickles et al, 2014).  It could be inferred that disease of a 
severity such that horses meet grade 1/5 on Newton’s scale, 1/3 on Talbot’s scale and 1/3 
on Roberts’ scale has minimal impact on welfare and utility to the owner and therefore 
minimal economic impact to the equine industry. Significant welfare and economic impact 
could be expected at the higher grades, with horses being retired or even euthanased if they 
cannot perform in their intended discipline. Of note are horses which would be classified as 






them, even retirement is not an option, which may leave only euthanasia should treatment 
options fail. 
  
GRADING SYSTEM SCALE CLASSIFICATION 
Newton, 2000 1 Intermittent and mild clinical signs. Facial muscle 
twitching. Rideable. 
 2 Moderate clinical signs. Definable conditions under 
which they occur/develop. Rideable with some difficulty 
 3 Rideable but unpleasant ride, difficult to control 
 4 Unrideable, uncontrollable 
 5 Dangerous with bizarre behaviour patterns 
   
Talbot, 2013 0 No headshaking 
 1 Mild signs at exercise 
 2 Obvious signs  
at exercise but no striking at the nose or behavioural 
changes 
 3 Most severe, with severe signs including behavioural 
changes and refusal to move 
   
Roberts, 2014 0 No signs of headshaking 
 1 Mild headshaking, insufficient as to interfere with ridden 
exercise 
 2 Headshaking at exercise of a severity sufficient as to 
make ridden exercise dangerous or impossible 
 3 Headshaking even at rest 
Table 1: Grading systems. 
At present there are no data considering the proportions of affected horses meeting each 
grading classification. Such data would allow better assessment of scale of impact, by 
calculating the proportion of horses with significant welfare compromise, those retired and 
euthanased and from that, the cost of wastage to the equine industry.  
There is potential for translational research, with clinical similarities being present between 
equine trigeminal-mediated headshaking and human trigeminal neuralgia. This potential may 
however be limited with the pathology present in most human trigeminal neuralgia patients 
being absent in equine trigeminal-mediated headshaking. 
1.5 Anatomy of the trigeminal complex 
The trigeminal complex is made up of both peripheral and central components (De Lahunta 
and Glass, 2009). Peripheral components are the trigeminal nerve (V cranial nerve), 
trigeminal ganglion, the 3 main branches (ophthalmic, maxillary, mandibular, Figure 1), and 







Figure 1: Peripheral components of the trigeminal complex. Ophthalmic nerve (OPH in 
green), maxillary nerve (MAX and its branch infraorbital nerve [IO], in yellow), mandibular 
nerve (MAN in red), and trigeminal ganglion (oval brown structure). Not all branches from 
each nerve are shown. Figure not drawn to scale. Image reproduced with permission from 
Dr. Monica Aleman (From Pickles K, Madigan J, Aleman M. Idiopathic headshaking: is it still 
idiopathic? Vet J. 2014 Jul;201(1):21–30; with permission.) 
The central components are made up of the spinal tract, likely to the second cervical spinal 
cord segment, and the nuclei of the trigeminal complex within the brainstem. 
The trigeminal nerve is the largest sensory cranial nerve (De Lahunta and Glass, 2009). The 
trigeminal ganglion has sensory cell bodies for pain and temperature modalities of all the 
sensory branches with proprioception going to the nuclei of the brainstem (De Lahunta and 
Glass, 2009). The mandibular branch also has motor function. This motor part of the 
mandibular nerve runs ventral to the trigeminal ganglion (De Lahunta and Glass, 2009). The 
ophthalmic nerve is the smallest of the 3 sensory branches and runs lateral to the cavernous 
sinus. The ophthalmic nerve enters the orbital fissure along with the oculomotor, trochlear, 
abducens, and sympathetic nerves to the eye. The ophthalmic nerve gives rise to the 
lacrimal, frontal, nasociliary, and ethmoidal nerves (Budras et al, 2009). The maxillary nerve 
emerges from the round foramen and continues into the maxillary foramen and infraorbital 
canal as the infraorbital nerve. The maxillary nerve has several branches which includes the 
zygomaticofacial, pterygopalatine, major palatine, minor palatine, caudal nasal, and 
infraorbital nerves (Budras et al, 2009). The caudal nasal nerve has been commonly referred 
to as the posterior ethmoidal nerve; however, these nerves are distinct structures arising 
from different branches of the trigeminal nerve. This is further discussed in Chapter Four. 
The mandibular nerve has many branches, which includes the masseteric, temporal, 






and mental nerves (Budras et al, 2009). The maxillary nerve is sensory to the lower eyelid, 
maxillary teeth, upper lip, maxillary sinus, and nose (Budras et al, 2009). The signs 
displayed by affected horses seem to be focussed on the muzzle/nose area leading to 
dysfunction of the maxillary nerve, and within that the infraorbital branch is in particular 
affected. 
1.6. Aetiopathogenesis 
The clinical signs of trigeminal-mediated headshaking are consistent with neuropathic pain 
of the trigeminal nerve. Although this was suspected in even the 19th Century (Williams, 
1897, 1899) there have been many other theories, with trigeminal involvement being only 
recently confirmed (Aleman et al 2013, 2014). Detailed nerve conduction studies of control 
and headshaking horses identified that the infraorbital branch of the trigeminal nerve of 
affected horses was sensitised, with a lower threshold for activation than non-affected 
horses (Aleman et al. 2014). Somatosensory evoked potentials recorded under general 
anaesthesia determined the threshold for activation for control horses to be greater than 
10mA, but less than 5mA for affected horses. It is presumed that trigeminal nerve 
sensitisation results in neuropathic pain. There were no differences in the neurophysiological 
characteristics of the action potentials. Additionally, there were no differences between left 
and right sides, consistent with bilateral involvement of the trigeminal nerve. One seasonally 
affected horse was tested out of season and demonstrated normal threshold activations, but 
was not also tested when showing clinical signs, to determine if threshold was then 
abnormal. Work is required to determine whether in cases where clinical signs resolve, this 
occurs in parallel with a return to normal nerve threshold function. This could help confirm 
that altered neurophysiology is potentially reversible.  
The reason for the sensitisation of the trigeminal nerve in trigeminal-mediated headshaking 
remains unknown. Whilst herpes virus is involved in the pathogenesis of some human 
neuropathic pain syndromes, the virus was shown not to be involved in the pathogenesis of 
trigeminal-mediated headshaking (Aleman et al, 2012). There seems likely to be a complex 
association with environment in developing this acquired condition, with anecdotal reports of 
onset shortly after relocation of the horse and less frequently, signs resolving after 
relocation. This may be supported by work suggesting a potential role for electrolytes 
(Sheldon et al 2018, Sheldon et al 2019a, Sheldon et al 2019b) with small studies showing 
first intravenous administration of magnesium, then oral administration of magnesium and 






The mechanism by which magnesium supplementation in the form of magnesium alone or 
magnesium in combination with boron resulted in significant reduction in headshaking 
behaviour is not completely understood (Sheldon et al, 2019b). Treatment with magnesium 
in combination with boron induced the greatest reduction in headshaking behaviour. This 
could be because of boron's ability to increase circulating magnesium 
concentrations. Magnesium could then provide its physiological channel blocking effects on 
N‐methyl‐D‐aspartate (NMDA) receptors and reduce ion currents. The NMDA receptors 
affect trigeminal neurons at the trigeminal subnucleus caudalis (the orofacial nocioceptive 
processing centre) in rats. Boron could also affect neurotransmitters because of its ability to 
form complexes with sugars. When boric acid forms ester complexes with ribose, a part of 
adenosine, boric acid will non-competitively inhibit adenosine diphosophate ribosyl cyclase 
(ADP‐ribosyl cyclase). This slows the production of cyclic ADP‐ribose (cADPR), in turn 
slowing mobilization of Ca2+. Furthermore, calcium might be involved in trigeminal 
neuropathic pain, but the exact mechanism is unknown (Sheldon et al 2019b).  
Trigeminal nerve root demyelination is the most frequent cause of human trigeminal 
neuralgia, a neuropathic facial pain syndrome (Love and Coakham, 2001). However, no 
histopathological abnormality of the nerve has been discovered in equine trigeminal-
mediated headshaking (Roberts et al 2017) which is explored in Chapter Three. Despite the 
apparent clinical similarities between trigeminal neuralgia and trigeminal-mediated 
headshaking, differing pathology was expected, as human trigeminal neuralgia sufferers are 
usually unilaterally affected and have abnormal conduction patterns due to demyelination 
(Love and Coakham, 2001). It can be considered a potentially positive result, as 
demyelination would be unlikely to be reversible. The lack of histological abnormality in 
trigeminal-mediated headshakers may suggest a functional, rather than structural, 
abnormality of the nerve. This may lead to the potential for developing a treatment which 
reverses the functional abnormality. The potential for reversal is supported by seasonality in 
many cases and an approximate 5% spontaneous remission rate (Madigan and Bell, 2001). 
This is further explored in Chapter Six. 
1.7 Diagnosis 
Diagnosis of trigeminal-mediated headshaking is currently made by exclusion, allowing 
potential misdiagnosis. Some papers’ case populations rely mostly on interpretation of 
clinical signs and even owner-led diagnosis. The use of diagnostic local anaesthesia has a 
place in proving but not disproving facial pain and does not reveal the cause of facial pain. 






infraorbital nerve threshold potentials could allow for this to be the gold standard for 
diagnosis but would be limited by a requirement for general anaesthesia. Exploring whether 
the procedure could be tolerated or modified and remain accurate when used on horses 
under standing sedation could be a diagnostic breakthrough. It would still be important to 
show there was no gross pathology such as dental disease leading to sensitisation to 
complete a diagnosis. 
i. Management 
With trigeminal-mediated headshaking the aetiopathogenesis is unknown, presenting the 
greatest challenge to finding effective treatment. It is possible that there is more than one 
cause with the same clinical manifestation, leading to different response rates to treatment. It 
is recognised in human medicine that response to treatment for neuropathic pain varies 
amongst individuals, even with the same diagnosis (NICE guidelines, 2018). Therefore, even 
if all horses with trigeminal-mediated headshaking have the same underlying condition, 
response to the same treatment may vary.  
To review the literature surrounding management strategies, consideration must be made of 
the reliability of diagnosis, the mechanism of assessment of response used, and placebo 
effect. Assessment of response to treatment can be challenging. Horses can vary from day 
to day and season to season in the severity of their signs and interpretation of these signs is 
heavily influenced by placebo effect (Pickles et al, 2011 and Talbot et al, 2013). The most 
objective measure currently available is classification of success as being return to ridden 
work at the previous level (Roberts et al, 2016, Chapter Six). Should data consistently 
demonstrate sensitisation of the infra-orbital nerve in horses with trigeminal-mediated 
headshaking, the next stage for research would be to determine whether in horses judged to 
have responded to treatment, threshold potentials have returned to normal. This could allow 
measurement of threshold potentials before and after treatment to give an objective measure 
of response to treatment. However, the procedure requires general anaesthesia which may 
limit its practical application (Pickles et al, 2014). 
Since there is a considerable placebo effect when interpreting results of treatments for 
headshaking (Pickles et al, 2011 and Talbot et al, 2013) trials of treatments for headshaking 
should ideally include placebo or control groups. However, this is not always possible due to 
welfare considerations in a group of horses suffering a painful condition. 
There are many treatments tried by owners of horses with suspected or confirmed 






(Roberts et al, 2020 Paper 7). Assessment of efficacy of unpublished treatments is 
particularly challenging; it is not known if a veterinary diagnosis was made, or whether the 
criteria for success are sufficiently robust as to compensate for placebo effect of the owner. 
Without published data, they are not further considered in this introduction. Published 
treatments are best considered in two categories: scientifically proven treatments and those 
with no effective results. 
The recent advances suggesting possible reversible sensitisation may give opportunity for 
advances in therapy, although these remain limited and early in their inception. The rationale 
behind more established therapies with some evidence of success appears to be to reduce 
sensory input from the trigeminal nerve, intended or not, even before sensitisation was 
confirmed.  
1. Scientifically proven treatments: 
i. Nose-net: 
This, shown in Figure 2, is the first treatment to trial as it is cheap, non-invasive, risk-free 
and is allowed in most competition at most levels. It is reported to give up to 70% relief in 
25% cases (Newton et al, 2000; Mills et al, 2002). The mechanism by which a nose-net 
may work is thought likely to be similar to (but not the same as it does not travel through 
the spinal cord) gate control theory. The substantia gelatinosa in dorsal horn of spinal cord 
appears to act as a gate control system. It modulates the synaptic transmission of nerve 
impulses from peripheral fibres to the nervous system. Small nocioceptive fibres hold the 
gate in an open position. Stimulation of large mechanoreceptive fibres by touch, pressure 
or vibration, close the ‘gate’ and inhibit pain transmission to the brain. Small nocioceptive 
fibres have a higher activation threshold than larger mechanoreceptive fibres. Selective 
low-level stimulation of mechanoreceptors can therefore prevent or reduce pain 
transmission and activation of the inhibitory pathway results in release endogenous opioids 
and other neurocompounds. 
There are a wide variety of nose-nets available on the market, although a far more limited 
range which is competition legal. The author advises owners to trial more than one variety. 
Some horses appear to show more severe signs when wearing a nose-net (personal 
observation). The main equestrian sport governing body, the Federation Equestre 
Internationale will be banning the clipping of the vibrissae of the muzzle from July 2021. 
Whilst the reasons for this are undoubtedly to improve welfare, as they give much sensory 






impact on horses suffering trigeminal-mediated headshaking who can on occasion benefit 
from the presumed reduction in sensory information given by clipping vibrissiae (personal 
observation). 
 
Figure 2: Horse wearing nose net. Image reproduced with permission of Dr. Kirstie 
Pickles. 
ii. Pharmaceuticals: 
There are drugs available for the treatment of neuropathic pain in people and some of 
these have been used in horses with trigeminal-mediated headshaking. Even in people 
with neuropathic pain, these drugs have inconsistent results and may confer side-effects 
including drowsiness. A challenge to the efficacy of treatment for neuropathic pain is a 
heterogeneity of the mechanisms of neuropathic pain and therefore heterogeneity of the 
best way to target its treatment (Fornasari 2017).  Carbamazepine, a sodium-channel 
blocking anticonvulsant, can be effective to treat some cases of trigeminal neuralgia in 






2014). The mechanism of action is again to reduce central nerve conduction. Not all 
sufferers respond, some respond only short-term but even a short-term response can aid 
diagnosis, and some experience side-effects (Zakrzewska and Linskey, 2014). The use of 
carbamazepine alone, or in combination with cyproheptadine, a centrally acting 
antihistamine and serotonin antagonist (serotonin plays a role in pain sensation), is 
published in trigeminal-mediated headshakers (Madigan and Bell 2001, Newton et al, 
2000). Results are mixed, and as with people, occasionally a positive response is merely 
short-term. Some horses may be affected by drowsiness so there may need to be 
consideration as to whether they are safe to ride/handle.  
Of first-line drugs used for neuropathic pain in people, use of gabapentin has been 
published in the horse (Davis et al, 2007) but not in cases of trigeminal-mediated 
headshaking, although it is trialled in some cases (personal observations). Gabapentin is 
an anti-convulsant acting on calcium channels, which are expressed in the spinal cord, and 
it is this which gives them its analgesic properties; indeed the number of voltage-gated 
calcium channels can increase in cases of neuropathic pain (Fornasari 2017). 
Pharmacology and therefore dosing regimen of neuropathic pain pharmaceuticals in the 
horse is often uncertain, although there is work on gabapentin (Dirikolu et al, 2007). There 
is evidence for low bioavailability of oral gabapentin ( 16.2 ± 2.8%, Terry et al, 2010). The 
highest commonly used dose is 20mg/kg and the low bioavailabilty may suggest this to be 
insufficient with behavioural effects such as sedation only being seen in a group of horses 
administered this dose intravenously, not orally (Terry at al, 2010). The author does use 
treatment trials of the 20mg/kg dose orally and has received reports of horses showing 
signs of sedation but no clear evidence of alleviation of headshaking signs beyond some 
reduction in severity which could be attributed to sedation. It is of note that the published 
case of use of gabapentin in a horse with neuropathic pain used a very low dose (2.3mg/kg 
per os) (Davis et al, 2007). 
It is the author’s interpretation of these studies that, as some individuals can respond well, 
these drugs can be worth trying as long as expectations are managed. It should be noted 
that use of these medications would not be allowed in competition, and this fact may be 
sufficient to limit further research in this area. They may also be cost prohibitive for long-
term use. 
iii. Magnesium and boron: 
There are three studies by Sheldon considering the effects of metabolic status on nerve 






(Sheldon et al, 2018; Sheldon et al, 2019a; Sheldon et al 2019b). Intravenous infusion of 
hypertonic sodium bicarbonate resulted in short-term alkalaemia, metabolic alkalosis and a 
reduction but not resolution of clinical signs of headshaking (Sheldon at al, 2018). Whilst 
this is not a practical treatment, it adds to our understanding which may enable 
development of practical treatment.  
The next studies by Sheldon (Sheldon et al, 2019a; Sheldon et al, 2019b) were based on 
the understanding that magnesium may have neuroprotective effects on nerve firing that 
could potentially dampen signs of neuropathic pain. Intravenous infusion of magnesium 
sulphate solution increased plasma total and ionised magnesium concentrations and 
significantly decreased clinical signs in horses with trigeminal-mediated headshaking 
(Sheldon et al, 2019a). Response to intravenous infusion led to trialling oral 
supplementation, which can be a practical long-term treatment.  Oral magnesium 
supplementation (24.2 mg/kg) of magnesium citrate decreased clinical signs in trigeminal-
mediated headshaking, but a better result was obtained when both magnesium citrate 
(24.2mg/kg) and boron citrate (40mg/kg) were supplemented, with boron increasing uptake 
of magnesium (Sheldon et al, 2019b). Whilst it should be noted that clinical signs did not 
resolve in these cases, (median headshakes per minute at trot were reduced from 12 to 4 
with an overall 64% reduction across gaits of handshakes per minute) oral supplementation 
of magnesium and boron should, in the author’s opinion, be used as part of a multi-modal 
approach to managing horses with trigeminal-mediated headshaking. 
iv. Homeopathy: 
Following homeopathic treatment of varying regimes, as part of a larger study into 
homeopathy, 93.3 % owners reported they felt their horses were improved (Mathie et al, 
2010). The possibility of placebo effect and the use of owners’ subjective evaluation should 
be considered. 
v. Sodium cromoglycate eye drops: 
Stalin et al (2008) published a short communication where administration of sodium 
cromoglycate (a mast cell stabiliser) eye drops were effective in three seasonally affected 
horses, returning them to ridden exercise. This could suggest allergic conjunctivitis as an 
aetiology in these horses. However, it appears that allergy is not the cause in the majority 
of headshaking cases and the author has been unable to replicate these results, although 







Bilateral infraorbital neurectomy (Mair, 1999) was effective in 3/19 horses with serious side 
effects being common; however, this study was important in that it added to the weight of 
evidence of involvement of the trigeminal nerve. 
Caudal ablation of the infraorbital nerve via coil compression achieved better results 
(Roberts et al, 2009 and Roberts et al, 2013, Papers 4 and 5) with approximately 50% 
success rate in 57 horses but 26% relapsed with a median time of nine months (range two 
months to five years). Most horses (30/48, 63%) developed the side effect of nose rubbing 
which was short-term in most cases but 4/58 were euthanased due to severity or non-
resolution. The author no longer recommends this procedure having developed a safer 
procedure with better outcomes (Roberts et al, 2020, Paper 7). 
vii. EquiPENS™ Neuromodulation: 
This technique was translated from percutaneous electrical nerve stimulation 
neuromodulation, a minimally invasive procedure which can have efficacy for the 
management of neuropathic pain in people (Bhaskar et al, 2011; Raphael et al, 2011). 
Potentially, the procedure is effective by normalising neural function, but no basic science 
has been performed to investigate the mechanism of action. An initial trial, using an 
electrical protocol based on humans and an initial three procedure course, was published 
in 2016 (Roberts et al, 2016, Paper 6). This demonstrated that the procedure was possible 
to perform under standing sedation, had minimal risk of side effects, and returned 5 of 7 
horses to ridden work. More data (Roberts et al 2020) on 168 trigeminal-mediated 
headshakers receiving EquiPENS™ neuromodulation (530 procedures) has followed. The 
complication rate was 8.8% of procedures and, in all but one case, complications were mild 
and transient, with no self-trauma. Remission of headshaking following the initial course 
occurred in 53% (72/136) of horses. Median length of time recorded in remission was 9.5 
weeks (range 2 days to 156 weeks ongoing). Where signs recurred, most horses went 
back into remission following future procedures, usually for longer than from the previous 
procedure. No predictors for outcome were determined. These data may suggest that 
EquiPENS™ neuromodulation, whilst clearly carrying limitations, is a good first-line 
treatment for horses which do not respond to a nose-net. Refinement of this procedure will 
remain limited, not only until we understand the aetiopathogenesis of trigeminal-mediated 








Electroacupuncture was attempted for the treatment of trigeminal-mediated headshaking, 
following the initial indication of possible success of EquiPENS™ neuromodulation and 
resulted in temporary improvement in 6 horses (Devereaux, 2017). Success was 
considered to be an improvement in signs as judged by the owner, with a median 
remission time from the third procedure of 18 days (range 6 – 71 days) (Devereaux, 2017). 
As we do not understand the mechanism of action of neuromodulation or 
electroacupuncture the only way to make a comparison is to evaluate the use of a uniform 
electroacupuncture technique to EquiPENS™ over a similar number of appropriately 
diagnosed horses. 
2. Treatments with no effective results: 
i. Feed supplement: 
Talbot et al, 2013, published a double-blinded, placebo-controlled trial of a commercial 
herbal feed supplement, marketed for treatment of headshaking. There was no effect of the 
supplement or the placebo as judged by veterinary surgeons but there was significant 
placebo effect of both the supplement and the placebo to the owner, who ‘felt their horses 
were improved’. This demonstrates the importance of using as objective a measure of 
success as possible.  
ii. Gonadotrophin releasing hormone vaccine:  
The use of this vaccine was investigated as the condition is often seasonal and may be 
more common in geldings. In a study of 15 horses (Pickles et al, 2011), there was no 
actual improvement as judged by veterinary surgeons but again one third of owners felt 
their horses were improved. Vaccination reactions were reported in 4/15 cases, some of 
which were severe. 
iii. Pulsed high dose dexamethasone: 
Pulsed high dose dexamethasone was not effective for treatment (Tomlinson et al, 2013). 
This is consistent with histological findings of no inflammation of the nerve and that 
trigeminal-mediated headshaking is not a response to allergy. 
iv. Various:  
Madigan and Bell (2001) performed a survey of owners of headshaking horses. Whilst 
limited by owner reported diagnosis and outcomes, with success of treatment judged by 






antihistamines, antimicrobial drugs, corticosteroids, non-steroidal anti-inflammatory drugs, 
melatonin, chiropractic treatment, acupuncture. 
This introduction covers the limited current knowledge of the causes and mechanisms of 
trigeminal-mediated headshaking, displays the background for the work presented in this 
thesis and demonstrates its place in the literature. It also displays the need for considerable 
further research into the condition. Very little is known about neuromodulation, and there is 
potential to expand this work using horses to improve our knowledge, which could impact on 
the management of neuropathic pain in people. Determining the aetiology of trigeminal-
mediated headshaking may open more doors for translational research. 
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Chapter Two: Prevalence. 
Prevalence of trigeminal-mediated headshaking within the UK equine population 
2.1 Candidate contribution: 
Paper One: 
The concept of this paper was mine, as I repeatedly found that I needed this information and 
that it was lacking. I worked with the other two authors to develop the project plan. I obtained 
ethical permission for the project. I secured an Inspire (Academy of Medical Sciences and 
the Wellcome Trust) studentship award to support this project, whilst introducing a veterinary 
undergraduate to basic research concepts. I worked with the first author to obtain the main 
funding for the project from a fund for postgraduate research within the University of Bristol’s 
veterinary clinics. The second author on this paper was of critical importance for her 
experience of the questionnaire software and in its analysis. My main role was the close 
supervision of a postgraduate student in the execution and writing of the second publication 
of her career.  
2.2 Paper One 
Prevalence of headshaking within the equine population in the UK 
Ross SE, Murray JK, Roberts VLH (2018) 
Equine Veterinary Journal 2018 Jan;50(1):73-7. ISSN 0425-1644 DOI: 10.1111/evj.12708 






Prevalence of headshaking within the equine population in the UK 
Ross SE, Murray JK, Roberts VLH  
Bristol Vet School, University of Bristol, Langford, North Somerset BS40 5HB 
Summary 
Reason for performing study: Headshaking in horses has been reported to be most 
commonly due to idiopathic neuropathic facial pain (trigeminal-mediated headshaking). 
The prevalence of headshaking in horses in the UK is unknown.  
Objectives: To estimate owner-reported prevalence of headshaking in horses in the UK 
and to report their case background and disease characteristics, as reported by owners.  
Study design: Cross-sectional web-based owner questionnaire.  
Methods: The questionnaire was advertised online via social media, horse forums, 
veterinary websites and equestrian magazines from 17th June 2016, until >1000 
responses had been obtained. All UK horse owners were eligible to complete the 
questionnaire, however only one questionnaire could be completed per owner. 
Results: The estimated prevalence of owner-reported headshaking in the sample 
population of horses (n = 1014), within the last year, was 4.6% (95% confidence interval 
3.5–6.1), whereas 6.2% (95% confidence interval 4.9–7.9) of horses were reported by 
their owners to have shown signs of headshaking at any time-point since ownership. 
There was no association of sex or breed. Nineteen percent of headshaking horses were 
reported to show headshaking at rest. Fewer than one-third (30.2%, n = 19) of 
headshaking horses had been examined by a veterinarian for headshaking. Of horses 
seen by a veterinarian, the cause for headshaking remained unknown in the majority of 
cases (57.9% responses) and trigeminal-mediated headshaking was reported as a 
diagnosis in just one case.  
Main limitations: The accuracy in data reporting by horse owners was not verified in 
this study. There may be a potential for bias towards overreporting due to the nature of 
survey participation. 
Conclusions: Within this sample, owner-reported prevalence of signs of headshaking 
within the last year, in horses in the UK was 4.6%. Over two-thirds of owners of 
headshaking horses did not seek veterinary intervention for headshaking. Trigeminal-
mediated headshaking was rarely reported by owners as a diagnosis. 
 








Headshaking is a condition whereby horses show repeated, uncontrollable, 
predominantly vertical movements of the head and neck, often accompanied by nasal 
irritation [1,2]. Headshaking is a significant cause of distress in some horses [1]. Even 
with extensive investigation, usually no physical cause for headshaking is found [3,4]. In 
most cases, headshaking is reported to occur due to an idiopathic neuropathic facial pain 
syndrome (termed trigeminal-mediated headshaking) [1,5,6]. Severely affected horses 
appear to have compromised welfare and significant self-inflicted trauma has been 
reported [7]. The determination that many cases occur due to pain is recent [6] and 
therefore likely to be under-recognised by owners and veterinarians. Many affected 
horses become dangerous to handle and ride and especially if the condition is not 
understood, may undergo several futile treatments. Horses that are unsuccessfully 
treated may eventually be subjected to euthanasia. A diagnosis of trigeminal-mediated 
headshaking is supported when no defined aetiology can be found on thorough 
assessment and examination [6]; thus excluding other causes of facial pain which 
include, but are not limited to, guttural pouch disease, dental pathology and sinus 
disorders. A recent breakthrough provided evidence that the trigeminal nerve in affected 
horses is sensitised, firing at too low a threshold [8]. This discovery paved the way for 
the proposal that the previously favoured term ‘idiopathic headshaking’ be replaced by 
the term ‘trigeminal-mediated headshaking’ [7,9]. While some progress has been made 
in recent times towards diagnosing and treating the condition, the prevalence of 
headshaking within horses in the UK has not been fully elucidated. The prevalence of 
headshaking within the UK horse population is a fundamental question, which, once 
answered, would reveal the scale of a potential welfare problem and may endorse further 
research into the pathogenesis and treatment of the condition. Furthermore, how 
frequently trigeminal-mediated headshaking is considered the cause for headshaking 
has not been investigated. The aim of this study was to investigate the owner-reported 
prevalence of headshaking in the general horse population in the UK. Secondary aims 
were to report case background and disease characteristics for headshaking in horses, 
as described by owners. 
Materials and methods 
An online questionnaire with the ‘neutral’ title Horse Health Questionnaire was compiled 
using Bristol Online Surveys (BOS)a (Supplementary Item 1). Questionnaires were 






accordingly. An online sample size calculator (Ausvet Epitools [10]) was used to 
calculate the sample size required to estimate the true prevalence of headshaking signs 
based on an estimated population size of 1,000,000 (i.e. large population), assumed true 
prevalence of 4%, assumed sensitivity and specificity of 0.95 respectively, confidence 
level of 0.95 and desired precision of 0.02. A sample size of 932 was calculated to be 
required. The questionnaire was advertised online via social media, horse forums, first 
opinion practices and equestrian magazines on 17th June 2016 and remained open until 
10th August 2016, once >1000 responses had been obtained. The questionnaire was 
accessible via a uniform resource locator (URL). Participants were required to be age 
≥18 years, live in the UK, and to own or have owned a horse within the last year. Owners 
who had sold or had their horse subjected to euthanasia within the last year were eligible 
to complete the survey. Respondents were restricted to completing a questionnaire for 
just one horse per owner. Owners of multiple horses were asked to choose the animal 
whose name came first in the alphabet. The questionnaire took most people <5 min to 
complete. Questions on headshaking were flanked by questions on laminitis and equine 
sarcoids. Equine sarcoid data are not presented here. There were 2 purposes to having 
the distractor questions. One was to disguise the area of interest to minimise response 
bias. The other, that figures for prevalence of laminitis in horses in the UK have been 
reported [11]. A comparison of those figures with our own, if similar, would offer 
reassurance that prevalence figures obtained for owner-reported headshaking are also 
reliable. The following definition of headshaking was used; ‘for the purposes of this 
survey headshaking is characterised by unexplained and uncontrollable movements of 
the head and neck that may affect the horse either at rest or during exercise.’ The 
following definition of laminitis was used, ‘for the purposes of this survey, laminitis is an 
episode of lameness which was either; a) diagnosed by a vet as laminitis or b) laminitis 
was strongly suggested based upon the following; lameness was present in all 4 limbs 
and the horse or pony stood with an altered stance and/or the horse or pony was 
reluctant to move and/or there was increased heat in all 4 hooves and/or laminitis was 
diagnosed by a farrier.’ Prevalence values and 95% confidence intervals were calculated 
using Ausvet Epitools [10]. The Kolmogorov–Smirnov test was used to assess age data 
for normality. Age was not normally distributed and thus median and interquartile ranges 
were reported. The Mann–Whitney test was used to compare median age of 
headshaking and non-headshaking horses. Association of sex (male/female) and breed 
(7 categories of breed, Table 1) with headshaking (yes/no) was assessed using a chi-






expected data points. Statistical tests were carried out in IBM SPSS Statistics Version 
23. Significance was set at P<0.05. 
Table 1: Age, breed and sex data for non-headshaking and for headshaking horses 
 
Variable Category Non-headshaking 
horses % (n = 949) 
Headshaking 
horses % 
(n = 65) 
Season of 
purchase 
Spring  26.2 (237)1 23.1 (15) 
 Summer 26.2 (237)1 32.3 (21) 
 Autumn 25.1 (227)1 21.5 (14) 
 Winter 16.0 (145)1 15.4 (10) 
 Don’t remember 3.2 (29)1 6.2 (4) 
 Not applicable 
(homebred) 
3.2 (29)1 1.5 (1) 
Age this 
year 
1–5 years 8.7 (83) 3.1 (2) 
 6–10 years 29.5 (280) 24.6 (16) 
 11–15 years 22.7 (215) 26.2 (17) 
 16–20 years 18.5 (176) 20.0 (13) 
 ≥21 years 16.8 (159) 18.5 (12) 
 Unknown 3.8 (36) 7.7 (5) 
Breed Arab or Arab X 4.6 (43)2 6.2 (4) 
 Cob or Cob X 15.4 (145)2 20 (13) 
 ID, ID X or ISH 13.8 (130)2 15.4 (10) 
 TB, TB X or TB X WB 18.6 (175)2 16.9 (11) 
 WB or WB X 12.2 (115)2 12.3 (8) 
 Native or 
Unknown pony 
breed 
20.5 (193)2 18.5 (12) 
 Unknown horse 
breed or other 
15.0 (141)2 10.8 (7) 
Sex Female 37.2 (353 44.6 (29) 
 Gelding 61.9 (587) 55.4 (36) 
 Stallion 0.9 (9) 0 (0) 
Data are percentage (number) of responses. X refers to crossbreed. ID, 







1 Indicates % derived from total number of responses with complete data 
(n = 904). 
2 Indicates % derived from total number of complete data (n = 942). 
 
Results 
Prior to closure of the survey, 1016 responses were returned. Two responses were 
excluded due to failure to comply with the inclusion criteria. 
Headshaking prevalence 
Of the horses in this sample population (n = 1014), 47 (4.6%, 95% confidence interval 
[CI] 3.5–6.1) were reported to have shown signs of headshaking in the last year. A 
further 16 (1.6%, 95% CI 1.0–2.6) were reported to have shown signs of headshaking, 
but not within the last year. Currently/previously affected horses are hereafter referred to 
as ‘headshakers’. An additional 2 horses were reported by their owners to have died 
(probably subjected to euthanasia) during the last year as a direct result of headshaking. 
For horses that were still alive and where no distinction was made regarding time of 
displaying signs of headshaking, the combined prevalence of headshakers was 6.2% (n 
= 63; 95% CI 4.9–7.9). 
Laminitis prevalence 
Of the horses in our sample population (n = 1014), 64 (6.3%, 95% CI 5.0–8.0) were 
reported to have had laminitis in the last year. A further 83 (8.2%, 95% CI 6.7–10.0) were 
reported to have had laminitis, but not within the last year. For horses that were still alive 
and where no distinction was made regarding when the horse suffered from laminitis, the 
combined prevalence was 14.5% (n = 147; 95% CI 12.5–16.8). 
Headshaking background 
Questionnaires included data for 65 headshakers. 
Age 
Age in 2016 was provided for 63 horses (Table 1). Respondents were asked to choose 
from the nearest whole number age but horses aged ≥21 years were grouped together 
and therefore exact age for horses aged >20 years could not be ascertained. Fifty 
headshakers (79.4%, 95% CI 67.8–87.5) were aged ≤20 years; the median age of this 






(79.5%, 95% CI 76.8–81.9) were aged ≤20 years; the median age in this group was 11 
years (interquartile range 9–15 years). There was no significant difference between the 
median age of headshakers and non-headshakers aged <20 years (P = 0.08). 
Breed 
A wide range of breeds were represented which were combined into 7 subcategories 
(Table 1). No evidence (P = 0.65) was found for an association between breed category 
and headshaking. 
Sex 
In total, 29/65 (44.6%) of headshakers were recorded as female (mare or filly) and 36/65 
(55.4%) were recorded as geldings (Table 1). A chi-squared test revealed no statistically 
significant association between sex and absence/presence of headshaking signs (P = 
0.23). 
Season of purchase 
There was no season of the year for which purchase of headshakers was 
disproportionate to purchase of non-headshaking horses (Table 1). 
Time of year headshaking first began 
Respondents were asked to indicate in which month headshaking first began. The 3 
most frequent months with respect to onset of headshaking signs were: May: 21.9% (n = 
14); April: 17.2% (n = 11); and March: 14.1% (n = 9; Fig 1). Considering season, 53.1% 
of horses (n = 34) first showed signs of headshaking in spring (March, April and May) 
and 17.2% (n = 11) first showed signs in summer (June, July and August). 
Time of year affected 
Considering horses for which data were available (n = 56), 89.3% (n = 50) were reported 
to headshake in summer, 76.8% (n = 43). were reported to headshake in spring, 32.1% 
(n = 18) were reported to headshake in autumn, and 19.6% (n = 11) were reported to 
headshake in winter (Fig 2). Of 56 headshaking horses, 19.6% (n = 11) were reported to 
headshake during all 4 seasons and 8.9% (n = 5) were reported to headshake over 3 
seasons. A larger proportion of headshaking horses, 42.9% (n = 24), were reported to 
headshake over just 2 seasons. Of these, the majority, 95.8% (n = 23) were affected 
during spring and summer. In addition, 39.3% (n = 22) of headshaking horses were 







Figure 1: Bar chart displaying the number of headshaking horses reported to first show 
signs of headshaking for each month of the year. 
 
Figure 2: Bar chart displaying the number of horses reported to headshake during each 






(September, October, November) and winter (December, January, February). 
Respondents were asked to pick all that applied. 
Weather conditions 
Respondents were asked to indicate which weather conditions, if any, they associated 
with headshaking in their horse (Fig 3). Headshaking was reported to be most commonly 
associated with sunshine in 79.4% (50/63) of horses and heat in 52.4% (33/63) of 
horses. 
 
Figure 3: Association between environmental conditions and signs of headshaking. All 
applicable environmental conditions could be selected. 
Clinical signs: 
Headshaking was reported to have been gradual in onset in 37.5% of cases (24/64) and 
sudden in onset in 35.9% of cases (23/64). In addition 26.6% of respondents (17/64) 
indicated that the horse had been headshaking since the beginning of their ownership. 
Owners were given a list of clinical signs and were asked to indicate which sign or signs 
best described their horse whilst headshaking. The most frequently reported clinical sign 
was vertical head movement reported in 78.5% (51/65) of horses, followed by excessive 







Figure 4: Bar chart displaying observed frequencies of clinical signs reported to be 
associated with signs of headshaking. Respondents were asked to select all that apply. 
Effect of exercise 
Of horses that were lunged, 53.2% (25/47) were reported to headshake during lunged 
exercise. Of horses that were ridden, 95.1% (58/61) were reported to headshake during 
ridden exercise. Of horses that were turned out, 26.4% (14/53) were reported to 
headshake at rest. Of horses that were stabled, 12% (6/50) were reported to headshake 
at rest. ‘Don’t know’ and ‘not applicable’ options were available. 
Severity 
Owners were asked to grade the ‘usual’ severity of headshaking under a range of 
conditions, based on the following grading criteria: 
• Grade 0 – there is no headshaking. 
• Grade 1 – there is headshaking, only at exercise but sufficiently mild that 
the horse may be ridden. 
• Grade 2 – there is headshaking at exercise to a severity as to make 






• Grade 3 – there is headshaking even at rest. 
The results are summarised in Table 2. A higher percentage, 31.8% (14/44) of horses 
were grade 0/3 (asymptomatic) with a nose-net, compared with 11.4% (5/44) of horses 
recorded as grade 0/3 without a nose-net. There was no apparent association between 
open spaces vs. hedgerow when considering reported headshaking grade. Respondents 
were asked to grade their horse considering headshaking at its worst. In total 50.8% 
(32/63) of horses were considered grade 1/3, 30.2% (19/63) were considered to be 
grade 2/3 and 19.0% (12/63) of horses were considered to be grade 3/3, at worst (Table 
2). The seasons for which the highest percentage of horses were typically assigned 
grade 0/3 were winter and autumn (Fig 5). The seasons for which the highest percentage 
of horses were typically assigned grade 1/3 were spring and summer. 
Veterinary intervention 
Of headshaking horses, 30.2% (19/63) were examined by a veterinary surgeon for 
headshaking, and 69.8% (44/63) were not. Of the horses examined by a veterinarian, 
respondents were asked to indicate which diagnostic procedure(s) had been performed, 
for which 18 responses were obtained. The most commonly performed test was dental 
examination performed in 83.3% of horses (15/18), followed by aural and 
ophthalmological examinations performed in 50.0% of horses (9/18) each. Endoscopy 
was performed less commonly in 38.9% horses (7/18). Radiographs of the head were 
performed in 22.2% of horses (4/18). The ‘other’ category of response was recorded 8 
times and included blood tests, allergy testing and an antihistamine trial. Both computed 
tomography and diagnostic analgesia were reported infrequently in just one horse each.  
Respondents were asked to indicate whether a cause had been diagnosed. Considering 
only horses that had been seen by a veterinarian, the cause remained unknown in 
57.9% (11/19) of cases, allergy was diagnosed in 36.8% (7/19) of cases and trigeminal-











































13.6 (8) 11.4 (5) 31.8 
(14) 
16.3 (8) 16.7 (8) 0 
1 60.7 
(37) 














18.4 (9) 25.0 (12) 30.2 
(19) 
3 9.8 (6) 4.0 (2) 7.8 (4)  8.5 (5) 6.8 (3) 2.3 
(1) 
4.1 (2) 4.2 (2) 19.0 
(12) 
Data are percentage (number) of responses. The proportion of horses reaching each 
grade of headshaking, considering headshaking at its worst severity, is also provided. 
Table 2: The usual grade of headshaking (H/S) assigned to affected horses, considering 
each of the variables listed. 
 
 
Figure 5: Bar chart displaying the distribution of usual severity of headshaking (based on 








There were 75.4% (49/65) of respondents that had attempted at least one form of 
treatment trial. In 12 horses, 3 or more treatments had been trialled. Treatments 
employed are listed in Table 3. Of all headshakers, 63.1% (n = 41) had been tried with a 
nose-net. An eye mask was the second most frequently trialled treatment in 35.4% (n = 
23) of horses. The treatments were examined individually to determine the effect of each 
treatment, based on reduction of severity grade (Table 3). Of the horses trialled with a 
nose-net, no effect of treatment was reported in 73.2% (n = 30); partial improvement was 
reported in 7.3% (n = 3) and full resolution reported in 19.5% (n = 8) of horses. 










Nose-net 63.0 (41) 73.2% (30) 7.3% (3) 19.5% (8) 
Eye mask 35.4 (23) 47.8% (11) 13.0% (3) 39.1% (9) 
Antihistamines 23.1 (15) 73.3% (11) 13.3% (2) 13.3% (2) 
Phenylbutazone 9.2 (6)1 80% (4) 20% (1) 0 
Steroids 9.2 (6) 66.7% (4) 16.7% (1) 16.7% (1) 
EquiPENS 3.1 (2) 0 0 100% (2) 
Other 6.1 (4) - - - 
Gabapentin 0 - - - 
Surgery for coil 
placement 
0 - - - 
Data are percentage (number) of responses. The following criteria were used: No reduction or 
worsening in grade = no effect. Reduction in grade of 1 or more to a value >0 = partial improvement. 
Reduction in grade to 0 = full success.1Data relating to effect of treatment missing or incomplete for 
one horse. 2Partial improvement reported excludes full resolution. 
Table 3: Treatments trialled and percentage of horses each treatment was trialled in. 
Change in severity score was calculated by considering the usual grade (0–3) of 
headshaking during the day and the usual grade (0–3) of headshaking during treatment. 
Discussion 
In the population studied, the estimated prevalence of owner-reported headshaking within 
the last year was 4.6%. The equine population of Great Britain in 2015 was estimated at 
944,000 [11]. This represents a significant number of horses that are likely to be afflicted 






Health Survey (NEHS) [12] where headshaking was the fifth most frequently reported 
internal medicine syndrome, accounting for 1.8% of all reported syndromes.  
In the current study, 6.3% of horses developed laminitis in the last year, 8.2% of horses 
developed laminitis more than one year ago, so the combined prevalence in this sample 
population was 14.5%. The frequency of equine laminitis has been previously reviewed; 
however, of the 10 publications deemed by the review authors to be the highest quality 
publications, only 2 were conducted in a general equine population and neither in the UK 
[13]. Menzies-Gow et al. [14] investigated the prevalence of laminitis in a UK rescue animal 
population over a 6-year period and found that each year between 7.9% and 17.1% of the 
population had at least one episode of laminitis. While the sample populations are non-
identical and rescue animals may be at increased risk compared to the general population, 
our findings are comparable. A more recent study using a population of non-laminitic ponies 
aged ≥7 years, reported prevalence of pasture associated laminitis to be 4.0, 6.7 and 9.9% 
after 1, 2 and 3 years cumulatively for that population [15]. Given that the present study did 
not exclude animals that had previously had laminitis, the results are reassuringly 
analogous. This provides confidence that the sample and reported prevalence were not 
leading to over-estimation of the prevalence of laminitis, or headshaking, with this 
population. 
The case background of headshaking horses has been previously reported [3,7]. Our study 
corroborates the assertion that headshaking is not a condition of the young horse; in this 
population the median age of headshakers aged ≤20 years was 12 years. No evidence was 
found for a sex or breed predisposition within the sample studied here. This is in contrast to 
the findings of Madigan and Bell [3] who reported that geldings and Thoroughbreds were 
over-represented. Approximately 1 in 5 headshaking horses were reported to headshake all 
year round, with the remainder affected for a variable proportion of the year. A seasonal 
component in some headshakers has been previously reported, of these, most started 
headshaking in the spring [3], in agreement with our findings. Worsening of signs with 
exposure to sunlight has also been documented [8]; however, the range of environmental 
conditions associated with headshaking reported here, which include cold and rain as well 
as heat and sun, highlight the practical difficulties in managing these cases. The results of 
this study do not support anecdotal speculation that more headshaking horses are sold 
during autumn or winter. 
Our survey suggests that approximately one in 4 headshaking horses show signs when 






that in more advanced cases, of longer duration, signs are more obvious at rest [2]. While it 
is well documented that exercise precipitates headshaking in many cases [3], horses 
affected at rest represent a particular welfare issue. Should treatment fail, retirement will not 
be curative in these cases, leaving euthanasia on welfare grounds as a viable option.  
Vertical head movements and rubbing of the muzzle were commonly reported clinical signs 
in this study. The clinical signs of head shaking can be reasonably interpreted as 
manifestation of the resulting neuropathic facial pain. The human condition trigeminal 
neuralgia is an exemplary condition of neuropathic facial pain [16] and one that shares some 
clinical similarities with trigeminal-mediated headshaking in horses. Pain associated with 
trigeminal neuralgia is characterised by debilitating electric shock-like pain and can lead to 
suicide within human individuals [17]. Reasons for the low level of veterinary intervention 
reported here were beyond the scope of the study and were not investigated. It is possible 
that horse owners perceive that veterinary investigation is often fruitless. Alternatively, it 
could be speculated that a lack of veterinary intervention could reflect that many owners 
simply do not associate signs of headshaking with expression of facial pain. 
Consensus in the literature indicates that treatments for headshaking are generally 
ineffective [1,2,5,8,18]. This study highlights that multiple treatments may be tried for any 
one horse. Our study reports the perceived effect of treatment from an owner perspective 
and thus findings must be interpreted with caution as there is evidence for placebo effect 
[19]. Secondly, due to the known component of seasonality [3,20] and spontaneous 
remission, any treatment for headshaking cannot be judged to have been effective in the 
long-term, unless an improvement is sustained for at least 12 months. Furthermore, we are 
reliant on memory recall and for some categories of treatment the sample size was very 
small; thus results must be interpreted with caution. 
This study suggests that trigeminal-mediated headshaking is not a common diagnosis for 
headshaking in horses attended by a veterinarian, as reported by owners. Diagnosis of 
trigeminal-mediated headshaking is based on detailed history and observation of phenotypic 
headshaking, combined with exclusion of other pathology [7]. Roberts [9] states, that the 
condition is idiopathic should be no excuse for not performing a thorough and systemic 
diagnostic process to investigate cases. However, this relies on veterinary attention being 
sought, and also upon owners committing to the financial costs associated with a complete 
investigation. The knowledge that detectable pathology is unlikely to be found in the vast 
majority of cases [21] may act to deter owners from consenting to complete investigation, if 






frequently; this may reflect lack of awareness of trigeminal-mediated (idiopathic) 
headshaking as a potential diagnosis or may reflect hampered ability of attending 
veterinarians to perform complete investigation. A lack of owner familiarity with the 
terminology is a further possibility and it may be the case that veterinarians do not use the 
terminology ‘trigeminal mediated’ or ‘idiopathic’ in conversation with clients, to avoid 
alienating owners with jargon. 
The purpose of this survey was to capture data on horses from horse owners in the general 
population; veterinary intervention was not a criterion for inclusion. The accuracy in data 
reporting by horse owners was not verified and is a major limitation of this study. The level of 
knowledge of the respondents completing the questionnaire cannot be vouched for and is a 
further limitation. In addition, potential exists for bias, particularly towards over-reporting of 
the condition, despite our efforts to provide both precise definitions and distractor questions. 
However, referral centres were deliberately not contacted in an effort to avoid potential bias, 
and over-estimation of prevalence, which may be associated with using a referral population. 
In conclusion, the findings of this study estimated the prevalence of owner-reported 
headshaking in horses within this sample of horses in the UK to be 4.6% for horses affected 
within the last year, and 6.2% for horses affected at any time point. 
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Chapter Three: Pathology. 
Trigeminal-mediated headshaking in horses is not associated with focal nerve root 
demyelination 
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manuscript, with all authors involved in the final approval of the version to be published. I 
presented the work at the 115th Annual Meeting of the British Neuropathological Society 
(2014). 
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Trigeminal nerve root demyelination not seen in six horses diagnosed with trigeminal-
mediated headshaking 
Roberts VLH1, Fews D1, McNamara J2, Love S3. 
1. Bristol Vet School, University of Bristol, Langford, North Somerset BS40 5HB 
2. Centre for Comparative and Clinical Anatomy, University of Bristol, Bristol 
3. Department of Neuropathology, University of Bristol Institute of Clinical 
Neurosciences, Southmead Hospital, Bristol 
Summary 
Trigeminal-mediated headshaking is an idiopathic neuropathic facial pain syndrome in horses. 
There are clinical similarities to trigeminal neuralgia, a neuropathic facial pain syndrome in man, 
which is usually caused by demyelination of trigeminal sensory fibers within either the nerve root 
or, less commonly, the brainstem. Our hypothesis was that the neuropathological substrate of 
headshaking in horses is similar to that of trigeminal neuralgia in man. Trigeminal nerves, nerve 
roots, ganglia, infraorbital, and caudal nasal nerves from horse abattoir specimens and from 
horses euthanized due to trigeminal-mediated headshaking were removed, fixed, and processed 
for histological assessment by a veterinary pathologist and a neuropathologist with particular 
experience of trigeminal neuralgia histology. No histological differences were detected between 
samples from horses with headshaking and those from normal horses. These results suggest 
that trigeminal-mediated headshaking may have a different pathological substrate from 
trigeminal neuralgia in man. 
Keywords: trigeminal-mediated, headshaking, idiopathic, horse, nerve root, demyelination 
Introduction 
Headshaking in horses is a syndrome of spontaneous and repetitive movements of the head 
and neck (1) predominantly in a vertical orientation (2). These movements are often 
accompanied by signs of nasal irritation (1, 2). The condition is usually worse at exercise (3) 
but may be seen at rest, in the stable and/or field (2). In the majority (98%) of cases, no 
physical cause is identified even after extensive clinical investigation (3). It is now widely 
accepted that most cases of headshaking are due to an idiopathic trigeminal neuropathy (1, 
2, 4–9) and the term “trigeminal-mediated headshaking” is the accepted term to describe this 
condition (10). 
The trigeminal nerve in trigeminal-mediated headshakers was shown to be abnormally 
sensitized, with an abnormally low threshold for activation when somatosensory-evoked 






was normal when the horse was tested out of season and therefore not showing clinical 
signs (11). This suggests a reversible disease process, although unfortunately the same 
horse was not tested when showing clinical signs. There is evidence that trigeminal-
mediated headshakers suffer facial pain, as signs can be temporarily abolished by infiltration 
of local anaesthetic around the caudal portion of the infraorbital nerve bilaterally (9). They do 
not respond to analgesia with non-steroidal anti-inflammatory drugs (6) but in some cases 
respond to carbamazepine and/or cyproheptadine (1, 6) or to neuromodulation by 
percutaneous electrical nerve stimulation (13), which would be consistent with neuropathic 
pain. 
Trigeminal neuralgia is a human neuropathic facial pain syndrome. It is usually caused by 
demyelination of trigeminal sensory fibers within either the nerve root or, less commonly, the 
brainstem (14). In most cases, the trigeminal nerve root demyelination involves the proximal, 
CNS part of the root and results from compression by an overlying artery or vein. Other 
causes of trigeminal neuralgia in which demyelination is involved or implicated include 
multiple sclerosis and, probably, compressive space-occupying masses in the posterior 
fossa (14). Determination of the underlying pathology has facilitated the development of 
targeted treatment. Initial histopathological examination of the infraorbital nerve of horses’ 
euthanized due to trigeminal-mediated headshaking did not reveal any abnormality but a 
comprehensive examination of the nerve, including the nerve root, was not reported (11). 
In this study, we investigated the possibility that the neuro-pathological substrate of 
headshaking in horses is similar to that of trigeminal neuralgia in man. 
Materials and methods 
Histopathological anatomy in normal horses 
Cadaver horse heads (four) were collected from an abattoir from horses presented for 
slaughter. Clinical history was unknown, but all had been assessed as fit for slaughter for 
human consumption on ante-mortem inspection. Controls were not age-matched to clinical 
cases. Heads were removed as routine during carcass preparation and immediately put into 
ice baths for transport. Dissection was performed within 3 h of slaughter. 
To access the caudal portion of the infraorbital nerve, the horses’ heads were cut using a 
band saw to access the caudal portion of the infraorbital canal. The first cut was a transverse 
slice that approximately bisected the angle of the mandible and masseteric fossa of each 
mandible. The second slice was along the length of the head following the line of the facial 






infraorbital canal was removed. The caudal third of the infraorbital nerve was transected 
rostral to the point parallel to tooth 110/210, back to the site of emergence from the brain. 
The trigeminal nerve on both sides of the head was removed to include the trigeminal nerve 
root, ganglion, infraorbital, and caudal nasal nerves. Specimens were fixed in 10% neutral 
buffered formalin, routinely processed to paraffin wax, sectioned at 4 µm, then stained with 
hematoxylin and eosin, Luxol fast blue/Cresyl violet, solochrome cyanin, or Palmgren silver 
impregnation. 
 








Histopathological Anatomy in Trigeminal-Mediated Headshakers 
Suitable cases (six) were horses diagnosed with trigeminal-mediated headshaking who had 
been euthanized following failure to respond to treatment. Owners gave informed consent for 
the use of their horses’ bodies for this study. Dissection was performed either within 1 h after 
euthanasia or up to 3 h later, when heads were again stored in ice. Dissection and slide 
preparation were performed by the same technique as for the abattoir specimens. As some 
cases had undergone “coil compression” of the infraorbital nerve for treatment of 
headshaking (2 and 9), the section of the infraorbital nerve affected by the surgery (level with 
the rostral border of tooth 111 and 211) was not used in this study. The histological 
appearance of samples taken from horses with headshaking was compared to the samples 
taken from normal horses, by a veterinary pathologist and a neuropathologist with particular 
experience of trigeminal neuralgia histology. Each sample was sectioned and examined at 
multiple levels. 
Results 
There were four assumed normal abattoir specimens and six clinical cases (20 nerves). Of 
the latter, three had undergone “coil compression” surgery, which had failed to alleviate 
clinical signs. The portion of the nerve affected by this procedure was not used in this study 
for any of the specimens (a 2-cm stretch of the infraorbital nerve, level with the rostral border 
of tooth 111 and 211). 
No histopathological abnormalities were detected on microscopic examination of the 
trigeminal nerve root, trigeminal ganglion, infraorbital nerve (excluding segments directly 
affected by coil placement), and caudal nasal nerve. In particular, there was no increase in 
cellularity or reduction of myelin staining to suggest demyelination, such as is often 








Figure 2: Microscopic features of the trigeminal nerve roots and caudal nasal nerves, 
including portions of the pterygopalatine ganglion, of control and affected horses, showing 
normal axons and myelination within the nerves and normal ganglion cells and architecture 
within the ganglia. (A) Photomicrograph control horse normal trigeminal nerve root H&E 
stain. (B) Affected horse normal trigeminal nerve root H&E stain. (C) Photomicrograph 
control horse including a portion of normal caudal nasal nerve and pterygopalatine ganglion 
H&E stained. (D) Affected horse including a portion of normal caudal nasal nerve and 







Figure 3: Photomicrograph of semi-thin sections through a region of trigeminal nerve root 
compression in a human patient reveals a zone of demyelination within the proximal, CNS 
part of the nerve root, close to the junction with the PNS. Several thinly myelinated fibres are 
present within the zone of demyelination. Toluidine blue. Reproduced with permission from 
Ref. (14). 
Discussion 
These results suggest that, while trigeminal-mediated headshaking in horses has apparent 
clinical similarity to trigeminal neuralgia in human, it may have a different underlying 
pathological substrate. 
Trigeminal neuralgia in people is a neuropathic facial pain syndrome characterized by a 
recurrent sudden, severe sharp electric shock-like pain (15). Certainly, trigeminal-mediated 
headshaking in horses is a facial pain syndrome, with signs of temporary amelioration 
following infiltration of local anaesthetic around the trigeminal nerve (9). Poor response to 
non-steroidal anti-inflammatory medication but response in some cases to administration of 
carbamazepine (6) and use of percutaneous electrical nerve stimulation (13) are consistent 






Both headshaking and trigeminal neuralgia appear to be acquired, although in people 
usually in an older equivalent population than in horses (15, 16). There are a number of 
other clinical differences. In trigeminal neuralgia, there is a slight female predominance (14, 
15), whereas trigeminal-mediated headshaking may be more common in neutered males 
(16) although clearly we cannot make a direct comparison here. Trigeminal neuralgia is 
typically unilateral (14, 15), whereas in horses the trigeminal nerve is affected bilaterally (11), 
so indeed the pathology could be central. Symptoms of trigeminal neuralgia are usually 
triggered by light stimuli, such as touching, chewing, talking, and tooth brushing involving 
specific mucocutaneous areas of the head, oral cavity, or neck: the “trigger zones” (15). 
Signs of trigeminal-mediated headshaking may be evident at rest but are often elicited by 
exercise (16), although in some cases signs manifest only when exercise is performed 
outdoors and not indoors (personal observation). In some cases, signs may occur only 
during the spring and summer months and may be worsened in bright sunlight and wind 
(16). This suggests a complex role of the environment in the development of the condition. 
People may suffer post-herpetic neuralgia (14), but trigeminal-mediated headshaking has 
been shown to not be associated with latent herpes virus infection (17). 
There are also differences at an electrophysiological level. The electrophysiological features 
of demyelination, such as temporal dispersion, polyphasia, and conduction block, are not 
seen in affected horses (18). Trigeminal-mediated headshakers instead, demonstrate 
sensitization of the trigeminal nerve, as evidenced by a low threshold potential for nerve 
activation when measured using somatosensory-evoked potentials (8, 11, 12). The 
sensitization appears to be reversible, as it was not evident in a seasonally affected 
headshaker when tested out of season and free of clinical signs. 
Present findings extend those of Aleman et al (11). There appears to be no structural 
abnormality in the trigeminal nerve of horses affected by trigeminal-mediated headshaking. 
A functional, non-structural abnormality may reflect central pathology or membrane instability 
and raise the possibility that the condition is potentially reversible, as occurs naturally in 
seasonally affected horses. Limitations of the present study include the small sample size 
without close age-matching of cases to controls, our assumption that abattoir specimens 
were not affected by trigeminal-mediated headshaking, and the selection bias for donated 
affected horses to be non-responders to current available treatments. There was opportunity 






Further work should be directed at determining the cause of the functional abnormality and 
the factors which induce it, as this knowledge would allow the development of targeted 
treatments.  
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Validation of the accuracy of needle placement as used in diagnostic local analgesia of the 
maxillary nerve for investigation of trigeminally mediated headshaking in horses. 
Wilmink S, Warren-Smith CM, Roberts VL.H 
Bristol Vet School, University of Bristol, Langford, North Somerset BS40 5HB 
Introduction 
Headshaking in horses is commonly a clinical sign of a facial dysaesthesia (abnormal 
sensation), suspected to be due to a neuropathy of the maxillary branch of the trigeminal 
nerve (Newton and others 2000, Roberts 2011, Roberts and others 2013, Pickles and others 
2014). A diagnosis of facial dysaesthesia can be made by observing a marked decrease in 
headshaking in response to local anaesthesia of the innervating sensory nerves (Roberts 
and others 2013, Pickles and others 2014). 
Where no cause of this facial dysaesthesia can be identified on endoscopy, imaging of the 
head, ophthalmological and dental examination the dysaesthesia is likely to be neuropathic 
(Newton and others 2000, Roberts and others 2013). 
The maxillary nerve exits the brain via the round foramen, runs cranially and enters the 
maxillary foramen into the infraorbital canal to become the infraorbital nerve. The infraorbital 
nerve innervates the upper check teeth and the skin of the muzzle. The caudal nasal nerve 
(CNN) branches off the maxillary nerve just proximal to the maxillary foramen and enters the 
caudal nasal foramen before running towards the dorsal meatus of the nasal cavity to 
innervate the nasal mucosa (Dyce and others 2002). In previous articles, the CNN has been 
called the ‘posterior ethmoidal nerve’ (Newton and others 2000, Roberts and others 2013), 
but due to possible confusion with the ethmoidal nerve which branches of the ophthalmic 
nerve rather than the maxillary nerve, we will refrain from using this term. 
Local anaesthesia of the infraorbital nerve as it leaves the infraorbital canal resulted in a 
decrease in headshaking in 3/19 (16 per cent) horses only (Mair 1999). However, local 
anaesthesia applied around the maxillary nerve at the location of the maxillary foramen 
resulted in a marked decrease in headshaking in 11 of 17 (65 per cent) and 23 of 27 (85 per 
cent) of presumed idiopathic headshakers (Newton and others 2000, Roberts and others 
2013). It is suspected there was a false negative result in at least some of the horses, as 3/4 
horses which did not respond to diagnostic local analgesia responded well to caudal 







The intended site of deposition of the local analgesic is around the maxillary and CNN 
(Newton and others 2000, Roberts and others 2013), but accuracy of needle deposition at 
this location using the approach described by Newton and others (2000) has never been 
confirmed. Deposition in different locations could explain some of the false negative 
responses. 
The objective of this study was to verify the exact location of injection when performing local 
anaesthesia of the maxillary and CNN and also to determine whether increased operator 
experience would result in a more accurate placement of the local analgesic. 
Thirty horse cadaver heads with no known clinical abnormalities were obtained from an 
abattoir. No selection for breed, age or sex had been made. Decapitation had been 
performed at the atlanto-occipital joint. All procedures were performed within three hours of 
decapitation. 
The heads were randomly assigned to one of three groups, with 10 heads to be injected by 
an experienced operator (VR) who has used local anaesthesia of the maxillary and CNN 
routinely on clinical cases (eight years’ experience with headshakers consisting 2 per cent of 
caseload, in total more than 100 cases on which this procedure has been performed). 
Another 10 heads were injected by a less experienced (learning) operator (SW) who had 
been trained by the first operator and had performed the procedure in four clinical cases 
before this study. The last 10 heads were injected by 10 final year veterinary students with 
no experience in performing the procedure. Prior to performing the procedure, all of the 
students were given access to the literature available to veterinary practitioners on the 
technique. This included the guidelines as described by Newton and others (2000), a video 
on placement of the injection which is included in a commercially available iPhone app 
(Equine Techniques) (Veterinary Advances, Ireland), anatomy books and an equine skull, 
but no further explanation was offered and no communication with other performers was 
allowed. All 12 performers were right hand dominant. The heads were positioned horizontally 
(ventral part of mandible resting on the table) on the CT machine (Siemens Somatom 
Emotion, Erlanger, Germany) scanning table. Injection around the maxillary and CNN was 
then performed bilaterally using the contrast medium amidotrizoate (Urografin 150, Bayer) 
(Bayer, Newbury, Berkshire, UK) and all performers used the approach as first described by 
Newton and others (2000) (technique shown in Fig 1). A 19 gauge 90 mm spinal needle was 
inserted on the ventral border of the zygomatic process of the temporal bone at the 
narrowest point of the zygomatic arch and directed rostromedially in the direction of the 






contact with bone was made. Aspiration was attempted before contrast injection and the 
stylet was replaced before needle withdrawal in an attempt to keep the contrast localised. To 
ensure good accuracy of measurements, only a 0.1 ml volume of a mixture of contrast 
medium was injected (Bardell and others 2010). 
 
Figure 1: Location of intended placement location of 19 gauge 19 mm spinal needle 
demonstrated in a horse skull and a clinical case 
Immediately following bilateral injection, CT images were obtained using a 4th generation 
helical CT scanner (Siemens Somatom Emotion). All heads were scanned from cranial to 
caudal using a 1.5 mm diameter slice thickness with a pitch of 0.9. Settings were kV of 130, 
mAs 190 (effective – Siemens CareDose 4D protocol) and a rotation time of one second. 
Reconstructions were obtained at a thickness of 1.2 mm to ensure that there was sufficient 
slice detail for multi-planar reconstructions. All images were then reviewed using commer-
cially available DICOM viewing software (Osirix, Pixmeo, Switzerland). Images were initially 
reviewed in the transverse plane to locate the contrast material. Dorsal images were then 






The location of the contrast injected was then noted and the distance from the target site. In 
some images, due to the three-dimensional nature of the skull, thick slice reconstructions 
were required to bring the location of the contrast injection into the same plane as the caudal 
nasal foramen. In order to assess placement zones correctly, the images were then 
reconfigured as thin slice images and rotated around the axis of the caudal nasal foramen to 
align the foramen and contrast injection site. All measurements were taken at the closest 
point of the visible contrast media to the caudal nasal foramen. 
The position of the injected contrast medium was divided into four zones depending on its 
position to determine the accuracy of the injection (Fig 2). Zone 1 represented contrast 
around the CNN nerve within and including at the entrance of the caudal nasal foramen 
where the CNN nerve branches off the maxillary nerve. Zones 2 and 3 lie between zone 1 
and a line drawn between the hamulus of the pterygoid bone and the caudal lateral tip of the 
caudal maxillary sinus. This region was then divided into equal portions based on the 
distance along the maxillary tuber to give zones 2 and 3 (see Fig 2). Zone 4 was all regions 
outside this area which included the orbit and represents a failure to place the contrast near 
the maxillary nerve. Designation to the zones were made and recorded by a single 







Figure 2: (a) Dorsal view of an equine head at the level of the maxillary foramen, with the 
location of zones used in this study. The caudal part of the infraorbital nerve and the caudal 
nasal nerve (CNN) are highlighted in red. Zone 1 represented contrast around the CNN 
nerve within and including at the entrance of the caudal nasal foramen where the CNN nerve 
branches off from the maxillary nerve. Zones 2 and 3 lie between zone 1 and a line drawn 
between the hamulus of the pterygoid bone and the caudal lateral tip of the caudal maxillary 
sinus. This region was then divided into equal portions based on the distance along the 
maxillary tuber to give zones 2 and 3 (see Fig 2). Zone 4 was all regions outside this area 
which included the orbit and represents a failure to place the contrast near the maxillary 
nerve. (b) Dorsal view of an equine head at the level of the maxillary foramen, with yellow 
circles highlighting the contrast medium in zone 1 (left) and zone 2 (right). 
Data are presented descriptively and a Kruskal-Wallis test was performed to examine the 
relationship between accuracy and the three groups of performers, followed by a Mann-
Whitney U test to examine significance in difference between each pair of groups. When it 






the experienced performer did inject around the maxillary nerve (zones 1, 2 and 3) more 
often than the other performers did. A Wilcoxon rank-sum test was used to determine the 
relationship between deposition zone and left or right side of the head. Statistical analysis 
was performed using SPSS Statistics for Windows V.19 (IBM, New York, United States). 
Significance was taken as P<0.05. 
The position of the contrast deposition was recorded for each head and the results for each 
zone, side of head and group are displayed in Table 1. Contrast is deposited around the 
maxillary nerve (zones 1, 2 and 3) in 53.3 per cent (32/60) of injections. 
 Zone 1 Zone 2 Zone 3 Zone 4 Zone 1+2+3 Total 
LEFT       
Non-experienced 0 (0%) 2 (20%) 1 (10%) 7(70%) 3 (30%) 10 
Learning 0 (0%) 1 (10%) 2 (20%) 7(70% 3 (30%) 10 
Experienced 0 (0%) 6 (60%) 1 (10%) 3 (30%) 7 (70%) 10 
Non-experienced + learning 0 (0%) 3 (15%) 3 (15%) 14 
(70%) 
6 (30%) 20 




13 (43.3%) 30 
RIGHT       
Non-experienced 1(10%) 2 (20%) 3 (30%) 4 (40%) 6 (60%) 10 
Learning 1(10%) 0 (0%) 3 (30%) 6 (60%) 4 (40%) 10 
Experienced 2(20%) 5 (50%) 2 (20%) 1 (10%) 9 (90%) 10 
Non-experienced + learning 2(10%) 2 (10%) 6 (30%) 10 
(50%) 
10 (50%) 20 




19 (63.3%) 30 
BOTH SIDES       
Non-experienced* 1(5%) 4(20%) 4 (20%) 11 
(55%) 
9 (45%) 20 
Learning* 1(5%) 1(5%) 5 (25% 13 
(65%) 
7 (35%) 20 
Experienced 2(10%) 11 (55%) 3 (15%) 4 (20%) 16 (80%) 20 




16 (40%) 40 






32 (53.3%) 60 
TABLE 1: Number of times contrast was located in each zone at each side of the head for 






including at the entrance of the caudal nasal foramen where the CNN nerve branches off 
from the maxillary nerve. Zones 2 and 3 lie between zone 1 and a line drawn between the 
hamulus of the pterygoid bone and the caudal lateral tip of the caudal maxillary sinus. This 
region was then divided into equal portions based on the distance along the maxillary tuber 
to give zones 2 and 3 (see Fig 2). Zone 4 was all regions outside this area which included 
the orbit and represents a failure to place the contrast near the maxillary nerve. The *, § 
symbols indicate which groups were compared with each other, where an equal number of 
symbols represents no significant difference and a different number of the same symbols 
represents a significant difference. CNN, caudal nasal nerve. 
 
The Kruskal-Wallis test showed a significant difference in accuracy amongst the three 
groups (H(2)=12.148, P=0.002) with a mean rank of 33.50 for non-experienced, 37.60 for 
learning and 20.40 for the experienced performer. The Mann-Whitney U test showed no 
significant difference in accuracy between the non-experienced and learning performers 
(P=0.478), but a significant difference between non-experienced and experienced 
performers (P=0.018) and also between the learning and experienced performers (P=0.001). 
Figure 3 shows the distribution over the zones where contrast was deposited by the 






Figure 3: The distribution over the zones where contrast was deposited by the experienced 
performer versus the other two groups combined. 
When the inexperienced group was combined with the less experienced performer into one 
group, and zones 1, 2 and 3 were combined into a result ‘hit’, a Fisher’s exact test could be 
used to compare the two groups. This confirmed that the experienced performer placed the 
injection around the maxillary nerve (zones 1, 2 and 3 combined) significantly (P=0.006) 







There was significant difference in accuracy between injections placed on the left or right 
side of the head, as determined by the Wilcoxon rank-sum test (P=0.046), with greater 
accuracy on the right as the median of the zones hit on the right-hand side was lower than 
on the left (zones 3 and 4, respectively). The injection was placed around the maxillary nerve 
in 43.3 per cent of injections on the left side, and in 63.3 per cent of injections on the right 
side of the head (Table 1). 
This study shows that contrast is deposited around the maxillary nerve (zones 1, 2 and 3) in 
53.3 per cent (32/60) of injections, and we found that accuracy is significantly greater when 
the procedure is performed by a very experienced performer. There was no significant 
difference in accuracy between those with little or no experience in placing the injection in 
this study. 
The use of one operator per category is not ideal and represents a limitation of the paper. 
However, given the limited number of experienced operators available, it was not possible to 
include more operators in the experienced or learning group. 
Injection did not always occur around the maxillary nerve as intended. Thus, a negative 
response to the local anaesthesia of the maxillary nerve in horses could result from failure to 
deposit local anaesthetic around the nerve. In clinical cases, accurate placement of the local 
anaesthetic can be confirmed to some extent by assessing sensitivity of the facial skin and 
nasal passage, which may help to distinguish a true negative from a false negative 
response. 
Injections placed on the right side of the head were significantly more accurate than 
injections placed on the left side of the head. All performers were right hand dominant. In 
clinical cases, a false negative response to bilateral local anaesthesia of the maxillary nerve 
and CNN would be more likely for remaining left-sided facial dysaesthesia. Signs of facial 
dysaesthesia in headshaking horses are usually bilateral (Aleman and others 2013). 
Therefore, unilateral application of the local anaesthesia has not been attempted by the 
authors in clinical cases. 
When performing local anaesthesia of the maxillary nerve and CNN in horses, a greater 
volume of local anaesthetic (5 ml) is used than the volume of contrast medium in this study 
(Newton and others 2000). Previous to this study, an attempt was made by the authors to 
analyse the location of deposition of 5 ml contrast medium, but description of anatomical 
structures involved proved difficult, complicating ensuing statistical analysis had this larger 






modalities rather than dye and dissection techniques enabled us to accurately locate into 
which zone the injection had been placed. The larger volume used in clinical cases will result 
in analgesia of a much larger area as the anaesthetic will diffuse along tissues, including 
more branches of the maxillary nerve than could be visualised in this study. Therefore, in 
clinical cases, success rate of anaesthetising the maxillary and CNN will be greater than 
reported in this study. The use of zones rather than absolute distances enabled us to 
overcome the variation in head size by standardising each head to itself and helped verify 
the accuracy of placement, although the distance of diffusion could not be accounted for. 
However, even when using a larger volume, deposition of local anaesthetic in zone 4 is 
unlikely to result in desensitisation of the maxillary nerve and will not lead to a decrease in 
headshaking even if this is due to facial dysaesthesia. This occurred in 24/40 (60 per cent) of 
injections by the non-experienced or less experienced performers and in 4/20 (20 per cent) 
of the injections performed by the experienced performer, suggesting experience is essential 
when performing local anaesthesia of the maxillary nerve and CNN. 
Possible complications of inaccurate injection of local anaesthesia around the maxillary 
nerve that have been observed by the authors in clinical cases include temporary loss of 
sight when the anaesthetic diffuses to or is deposited around the optic nerve, swelling of the 
retrobulbar fossa when disruption of an artery or vein results in a haematoma, or sudden 
distress when the needle touches the nerve. These side effects do resolve with time 
(Tremaine 2007). 
We consider it to be good practice to perform diagnostic local anaesthesia around the 
maxillary nerve and CNN on presumed idiopathic headshakers (Roberts and others 2013). A 
marked decrease in headshaking in response to application of diagnostic local anaesthesia 
around the maxillary nerve and CNN without other pathology in the innervated area will 
support the diagnosis of trigeminal (maxillary) neuropathy to the veterinarian, the owner of 
the horse and may also be used as proof for insurers. However, the possibility of a false 
negative outcome must be considered and preferably explained to the client before 
performing the diagnostic local anaesthesia around the maxillary nerve and CNN. 
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Chapter 5: Treatment I 
Modification of the original infraorbital neurectomy technique and consideration of 
risks 
5:1 Candidate contribution 
Paper Four was my first original research study. The concept was that of the second and last 
authors. I was equally involved with them in project planning. I performed the data collection 
with input from the third author in contacting horse owners. I performed the data analysis 
under supervision of the second and last authors. I wrote the manuscript with input from the 
third author and under the supervision of the second and last authors. A clear improvement 
in my papers can be seen over the years from this start point. 
Paper Five built on and expanded the study presented in Paper Four. The concept was mine 
and I planned the project with the supervision of the last author. I performed the majority of 
data collection with input from co-authors with data from their own institutions. I performed 
the data analysis and wrote the manuscript with input and agreement from all authors on the 
final version submitted for publication. 
5.2 Paper Four 
Caudal compression of the infraorbital nerve: a novel surgical technique for treatment of 
idiopathic headshaking and assessment of its efficacy in 24 horses. 
Roberts V.L.H., McKane S.A., Williams A. and Knottenbelt D.C. 







Caudal compression of the infraorbital nerve: a novel surgical technique for treatment of 
idiopathic headshaking and assessment of its efficacy in 24 horses. 
Roberts V.L.H., McKane S.A., Williams A. and Knottenbelt D.C. 
Faculty of Veterinary Science, University of Liverpool, Leahurst, Neston, Wirral CH64 7TE 
Keywords: horse; headshaking; trigeminal neuropathy; coil compression 
Summary 
Reasons for designing and reporting technique: Idiopathic headshaking has remarkable 
similarities to human neuropathic facial pain syndromes associated with post herpetic and 
trigeminal neuralgia. These derive from abnormal sensory function within the peripheral or 
central pathways of the trigeminal nerve (TgN). Limiting input from the TgN can be helpful in 
controlling the perception of pain. Rhizotomy of the infraorbital branch of the TgN as it 
emerges from the infraorbital canal has been reported but has a poor efficacy. A novel 
technique involves compression of the nerve at a more caudal location within the infraorbital 
canal and the technique requires validation. 
Hypothesis: Caudal compression of the infraorbital nerve with platinum coils, performed in 
horses diagnosed with idiopathic headshaking, results in a decrease in clinical signs.  
Methods: Caudal compression of the infraorbital nerve, using platinum embolisation coils, 
was performed under fluoroscopic guidance. Clinical records of 24 idiopathic headshakers 
that had undergone this procedure were reviewed. Follow-up information was obtained by 
telephone questionnaire with the owner or referring veterinary surgeon. 
Results: All 24 horses had at least one surgical procedure. Median follow-up time was 6 
months. There were 2 horses which had surgery 2 weeks before follow-up and these were 
excluded from the analysis of outcome. Following one surgery, 13/22 horses (59.0%) had a 
successful outcome. Of the 9 horses that did not improve, surgery was repeated in 6 cases. 
Two of these horses had a successful outcome. Overall, a successful outcome was obtained 
in 16/19 horses (84.2%).  
Conclusions: This surgical technique is likely to prevent input from the TgN at a more caudal 










The aetiopathogenesis of idiopathic headshaking is probably a trigeminal disorder (Neal and 
Ramsey 1972; Cook 1980; Wilkins et al. 1993; Newton et al. 2000). There may be abnormal 
sensory function within the peripheral or central pathways of the trigeminal nerve (TgN) 
(Weigel and Casey 2004). Whether the disorder has a peripheral or a central origin, either 
limiting input from the TgN or reducing brain stem response to input can be helpful in 
controlling the perception of pain associated with summation. This is the rationale behind 
current therapies for headshaking in horses. 
Nose nets have been reported to provide up to 70% relief in 25% of cases (Mills and Taylor 
2003). This may result from constant stimulation of the cutaneous components of the 
maxillary branch of the TgN (Newton et al. 2000). This stimulation is suggested to activate 
non-nocioceptive signals carried into the spinal cord by large nerve fibres. According to the 
gate-control theory, the action potentials in the large nerve fibres activate the inhibitory 
interneuron that would then block the projection neuron and, therefore, block the 
nocioceptive input. 
Reported medical therapies include cyproheptadine and carbemazepine, either alone or in 
combination. Cyproheptadine, an antihistamine and serotonergic agent, was reported by 
Madigan and Bell (2001) to result in a moderate to substantial improvement in clinical signs 
in 43/61 (70.4%) cases. However, Newton et al. (2000) found cyproheptadine alone to be 
ineffective. The addition of carbemazepine, a sodium-channel blocking anti-convulsant drug, 
resulted in 80–100% improvement in 80% cases. Carbemazepine alone was effective in 
88% cases. However, anecdotally, results are short-lived. Furthermore, long-term drug 
therapy is expensive and little is known about the pharmacokinetics of these drugs in horses, 
making it difficult to prescribe a safe and effective dosing regimen. Both drugs cause 
drowsiness as a side effect, which may mean horses undergoing treatment are unsafe to 
ride. Furthermore, these therapies are included on the banned substances list for many 
equestrian competitions. 
Bilateral infraorbital neurectomy was the first reported surgical treatment for idiopathic 
headshaking (Mair et al. 1992; Mair 1999), with a success rate of 3/19 (15.8%), but 8/19 
horses showed an increase in severity of headshaking following that procedure. Post 
operatively, 16 of 19 horses developed self-trauma to the nostrils or side of the face lasting 
for 3–8 weeks. Failure of this technique may be expected if the stimulus to headshake 
originates within the trigeminal nerve branches in a more proximal site closer to the 






100% resolution of clinical signs in 5/5 horses (Newton et al. 2000). However, the benefit 
lasted only 6 weeks to 10 months. 
Caudal compression of the infraorbital nerve was designed to permanently limit input from 
the TgN at a proximal location. Compression using platinum coils was chosen since 
neurectomy is not feasible due to anatomical location and is undesirable owing to the risk of 
neuroma formation. It was hypothesised that coil placement results in pressure degeneration 
of the nerve. Due to variation in anatomy of the TgN between individuals (Newton 2001), the 
technique may also cause compression in a location that reduces function of the posterior 
nasal branch in some cases. 
In this paper, the surgical technique and results in 24 cases of idiopathic headshaking are 
described. 
Materials and methods 
The clinical records of 24 horses that had undergone caudal compression of the infraorbital 
nerve using platinum coils at The Philip Leverhulme Equine Hospital between June 2004 
and October 2007 were reviewed. The surgical procedure was performed only in those 
cases where investigations found the horses to be idiopathic headshakers. Furthermore, 
these horses had all been non- or poorly responsive to more conservative therapy, such as 
use of a nose net. 
Case selection and details 
On admission, owners were interviewed and the information recorded included general 
details about the horse (age, sex, breed, use) and more specific information about the 
headshaking. The type of headshaking (horizontal, vertical or both) and whether it was 
accompanied by striking at the nose with the forelimbs or rubbing the nostrils were noted. On 
occasion, nose rubbing resulted in the development of facial sores, so the presence or 
absence of skin damage was recorded. Owners were asked in which situations their horse 
would headshake: at rest, in the stable, at pasture, ridden and when lunged. Owners also 
indicated in which of these situations they deemed the headshaking to be most severe. 
Trigger factors were further investigated, with the owners reporting whether the horse 
showed signs in sunny weather, windy conditions, rain or any combination of these. Where 
horses had a longer than a 12-month history of headshaking attempts were made to assess 
whether the complaint had a seasonal pattern. 
Investigations were carried out to rule out causes of headshaking other than an idiopathic 






examination. Lateral-lateral radiographs1 were taken of the skull at exposures suitable for 
viewing the roots of the cheek teeth and sinuses. Endoscopy2 was performed of the upper 
respiratory tract and guttural pouches of all cases. Moderate pharyngeal lymphoid 
hyperplasia (PLH) was detected at endoscopy of Case 22. This horse was discharged on a 
course of inhaled corticosteroid and then presented for re-examination 6 weeks later. 
Endoscopy showed the PLH had resolved but there had been no change in headshaking 
suggesting that the inflammation was likely to be an incidental finding. No significant 
abnormalities were detected in the other cases. There appeared to be a wide variation 
between individuals in the configuration of the infraorbital canal, which ranged from straight 
to curved. 
All horses were observed to headshake during hospitalisation, either at rest, on the lunge, 
ridden and/or during treadmill exercise. The horses that underwent treadmill exercise 
evaluation were trained to trot on an indoor treadmill3. Pollen was released into the airstream 
created by the fan positioned approximately 1.5 m in front of the horse’s nose. Once horses 
were seen to headshake consistently, diagnostic local analgesia of the posterior nasal nerve 
(Newton 2000) was performed in those judged to be suitable candidates for the procedure 
on the grounds of temperament. These horses were then reassessed under the same 
conditions. 
A total of 31 surgical procedures were performed on 24 horses diagnosed as idiopathic 
headshakers, therefore fulfilling the criteria for caudal compression of the infraorbital nerve 
using platinum coils. There were 6 horses (Cases 1, 4, 7, 14, 19 and 17) that received a 
second surgery after showing poor response to a first surgical attempt. Radiography showed 
that the coils had migrated in all of these cases and were therefore unlikely to be applying 
suitable pressure to the nerve within the infraorbital canal. A third surgery was required in 
Case 7. Case 12 had shown preoperative nose rubbing only on the left side. It responded to 
a unilateral posterior nasal nerve block on the left side so coils were implanted only into the 
left infraorbital canal. 
Surgical technique 
Following induction of general anaesthesia, the horse was placed in lateral recumbency, and 
a 5 x 5 cm area centred over the infraorbital foramen surgically prepared. A 2 cm skin 
incision was made over the infraorbital foramen, parallel to the facial crest. Blunt dissection 
was used to separate the subcutaneous tissue and the levator nasolabialis muscle was 






grossly hypertrophied (as is common in headshaking horses) it had to be split to allow 
access to the infraorbital foramen. 
Firstly, one platinum embolisation coil introducer4 (Fig 1) was prepared by removing the 
platinum coil and inserting a stylet to a point level with the tip of the introducer, to provide the 
necessary rigidity for initial advancement. The introducer with stylet was advanced along the 
infraorbital canal parallel with its natural path, under fluoroscopic guidance. Once the 
introducer was located securely in the canal, the stylet tip was advanced beyond the distal 
end of the introducer. This created a semiflexible guide to assist the passage of the more 
rigid introducer as it followed the curvature of the infraorbital canal. Static and continuous 
fluoroscopy5 were used to image the position of the introducer to ensure that it did not break 
out of the fragile infraorbital canal. The introducer was gently advanced along the canal until 
the point was just rostral to the most caudal maxillary cheek tooth, i.e. at the maxillary 
foramen (Fig 2). 
 







Figure 2: Fluoroscopic image of placement of first introducer. 
Once the first introducer was in position, the procedure was repeated with 2 or 3 additional 
introducers placed to completely fill the canal (Fig 3). At this stage, the stylet was removed 
from the first of the pre-placed introducers and another introducer, this time containing a 
platinum coil, was inserted into the hub of the first pre-placed introducer. The stylet was then 
used to advance the coil into the canal of the first preplaced introducer. The second 
introducer was detached and the stylet used to advance the coil out into the infraorbital 
canal, where the material’s memory causes it to form tight coils (Fig 4). Continuous 
fluoroscopy was used to observe accurate deployment of the coil. This was repeated for the 
other 2 or 3 preplaced introducers. The objective was to fill the width of the canal with tightly 
packed platinum coils to maximise pressure necrosis of the nerve. The introducers were 
removed and the skin incision closed using absorbable suture material in a sub-cuticular 
pattern. Where the muscle had been split, this was not sutured. The horse was then turned 







Figure 3: Four introducers in place, with stylets. 
 








Figure 5: Post-operative radiograph showing positioning of coils. 
Peri- and post-operative care 
Antimicrobial therapy was provided with penicillin (Depocillin6, 12 mg/kg bwt, i.m.) 
administered as a single dose preoperatively only, unless any perioperative complication, 
such as an introducer puncturing through the infraorbital canal wall into the sinus, suggested 
a longer course was advisable. Flunixin meglumine (Meflosyl7, 1.1 mg/kg bwt, i.v.) and 
morphine (Morphine B.P.8, 0.3 mg/kg bwt, i.v.) were administered to provide perioperative 
analgesia. Post-operative analgesia was maintained with phenylbutazone (Equipalazone9, 
2.2 mg/kg bwt, per os) as required. Horses were discharged from the hospital between 2 and 
5 days after surgery. 
Intra-operative complications 
During surgery, care had to be taken not to force the introducer needle through the wall of 
the canal into the sinuses, which would result in epistaxis. When this occurred the needle 
was re-directed. 
Some individuals had more pronounced curvature of the infraorbital canals than others. This 






these individuals it proved necessary to bend the introducer to accommodate the curvature 
prior to insertion. 
Post-operative complications 
Transient nose-rubbing, usually resulting in self-trauma and often accompanied by 
headshaking at rest, was a frequent post-operative complication. Where horses developed 
this problem after hospital discharge, they were managed by their attending veterinary 
surgeon. If the post-operative complication began before discharge, then a single dose of 
dexamethsone (0.1 mg/kg bwt, i.v., Duphacort)7 was administered and acepromazine (0.15 
mg/kg bwt daily, per os, Sedalin)10 prescribed as required. In these cases, number of days 
from surgery to onset of the complication was recorded. 
Follow-up information was obtained for all 31 procedures in the 24 horses by telephone 
interview with the owner. Owners were asked whether the horses had shown self-trauma 
from nose-rubbing after surgery and, if so, when this had occurred and when it resolved. 
The outcome of surgery was classified as successful if signs were alleviated sufficiently to 
allow the horse to be ridden when exposed to the stimulus that historically had caused it to 
headshake most severely. Hence some horses with a successful outcome may still have 
exhibited a mild degree of headshaking on occasion. There were 2 horses that were most 
affected when at rest. Case 14 was most severely affected in the stable and therefore 
success for this horse was judged on whether signs had alleviated when stabled. Case 8 
was an unbroken yearling whose signs were triggered by rain and success was therefore 
judged on the owner’s report of the horse’s behaviour when turned out during rainfall. 
Horses not yet back in work after surgery were excluded from analysis of outcome. 
All information was recorded in an Excel spreadsheet and descriptive statistics were 
generated. 
Results 
Descriptive information on the 24 horses is included in Table 1. There were 17 geldings and 
7 mares. A wide range of breeds was represented. The most common use was general 
riding (12/24) with 5 dressage horses, 2 showjumpers, 2 used predominantly for ridden 
showing, one eventer and one child’s mounted games pony. Cases 6, 10 and 24 had 
previously been racehorses. Median age at presentation was 8.5 years (mean 8.7 years, 
range 1–14 years). Weight at first surgery was recorded for 23/24 horses. Median weight 







Table 1: Age, breed, sex, use and weight of 24 cases of horses subjected to surgery. 
Specific information regarding the headshaking characteristics in each horse is shown in 
Table 2. There were 20/24 cases for which the owners knew whether or not the condition 
had a seasonal pattern. Of these, 11/20 (55%) were classified as seasonal headshakers and 
9/20 (45%) displayed headshaking behaviour all year round. Signs in seasonal headshakers 
were generally alleviated in the winter months. Considering possible trigger factors, 10/20 
(50%) horses showed increased severity of headshaking in sunny weather, 8/22 (36.4%) in 






their owners to show most severe headshaking signs when ridden. Not all owners had 
attempted lungeing their horses but of the 21 that had, 18 (85.7%) horses also showed 
headshaking on the lunge. Of the horses that displayed headshaking at rest there were 
13/22 (59.1%) that showed signs in the field and 11/22 (50%) that showed signs when 
stabled. 
 
Table 2: Details (season, location, activity, meteorology, behaviour and presence of sores) 
headshaking occurrence and behaviour as reported by owner in 24 horses subjected to 
surgery for headshaking. 
Considering the type of headshaking, a majority (21/23, 91.3%) showed vertical 
headshaking. There were 5/23 (21.7%) that showed horizontal headshaking with 3 horses 
(Cases 16, 23 and 24) showing both patterns. Striking at the nose was a feature in 14/21 
(57.1%) cases. Nose rubbing occurred in 16/23 (69.6%) resulting in facial sores in 6 of those 
cases. 
Details and results of surgery are recorded in Table 3. All 24 horses underwent at least one 
procedure. There were between 2 and 5 coils placed into each infraorbital canal. Surgery 







Table 3: Details (number of coils) period of follow-up, post-operative rubbing, second 
surgery success in 24 horses subject to surgery for headshaking and results of surgery. 
Median time to follow-up after the first surgery was 6 months (mean 9.5 months ranging from 
2 weeks to 29 months). Cases 23 and 24 had surgery only 2 weeks before follow-up 
information was sought. These had not yet been brought back into work and so were 
excluded from the analysis of outcome. Considering the remaining 22 horses, after one 
surgery 13/22 (59.0%) had a successful outcome; 9 did not respond to a first surgery, of 
which 6 (Cases 1, 4, 7, 14, 17 and 19) were returned for re-evaluation. All of these showed 
evidence of coil migration on skull radiography and a second procedure was therefore 
performed. Of these 6, 2 were still in the post-operative recovery period at the time of follow-
up and one had been unable to be ridden since surgery due to laminitis. These 3 were 
excluded from analysis of outcome. Considering the remaining 3, 2 had a successful 
outcome and one did not. This individual (Case 7) returned for a third procedure, which had 
a successful outcome. 
Overall, therefore, a successful outcome was obtained in 16/19 (84.2%) cases. Of these, 13 
were in ridden work throughout the year and one was as yet unbroken. There were 2 horses 
(Cases 7 and 11) that could not be ridden through 2 summer months due to headshaking, 






Nose-rubbing, resulting in self-trauma to the skin of the face and muzzle and often 
accompanied by headshaking at rest, was a frequent post-operative complication. Following 
the first surgery, 11/24 (45.8%) horses displayed nose-rubbing. Median time from surgery to 
onset of this complication was 4 days (mean 3.6 days, range 1–5 days). Duration of this 
complication was, for most horses, less than one month but Cases 17 and 11 were affected 
for 4 and 5 months each. Therefore, median time of duration of nose-rubbing was 14 days 
(mean 35.7 days, range 3–150 days). 
Discussion 
Caudal compression of the infraorbital nerve is an effective surgical treatment for idiopathic 
headshaking, where the aetiology is suspected to be a trigeminal nerve (TgN) disorder and 
no other possible causes are detected on investigation. It is suggested that the technique is 
likely to limit the sensory input from the TgN distal to the position of the coils, without actually 
obliterating it. 
Where the stimulus for an individual to headshake originates from a position distal to the 
coils, this should be effective in alleviating clinical signs associated with summation within 
the nerve. We suspect that prevention of transmission occurs because placement of the 
coils within the infraorbital canal results in pressure degeneration of the nerve. This is the 
case in rabbits subjected to balloon compression of the TgN (Brown et al. 1996). It is not 
possible however, to confirm our hypothesis without performing a necropsy examination 
some weeks post-surgery. We have not yet had the opportunity to do this. Without necropsy 
examination, it is also not known whether the presence of the coils has an effect on 
circulation in the blood vessels in the infraorbital canal. Due to variation in anatomy between 
individuals (Newton 2001), the interruption in nerve transmission may occur distal or 
proximal to the origin of the posterior nasal nerve branch. Without experimental 
neurophysiological studies and necropsy examination of both individuals in which surgery 
has been successful and those in which it has failed, it is not yet possible to determine the 
importance of preventing transmission from this nerve in alleviating headshaking. However, 
it is clear that, as most headshakers appear to have maxillary related signs, this approach 
would seem rational. 
It is unclear when to expect pressure degeneration of the nerve to be complete and, 
therefore, at what time after surgery to test the results. Therefore, owners were advised to 
test the results by exposing the horse to the stimulus to which it normally headshakes at one 
month after surgery, or 2 weeks after nose-rubbing ceases should the horse develop that 






monthly intervals was recommended. Horses that continue to headshake beyond 3 months 
after the time of surgery or cessation of nose-rubbing were found not to show any further 
improvement. 
The surgical technique continues to be refined and further validation is required in the future. 
Furthermore, repeat follow-up of the 24 horses is required in order to determine the longevity 
of success. Mair (1999) reported only 3 cases that had long-term success following 
infraorbital neurectomy, but a further 3 cases had short-term resolution of signs. Of these, 
clinical signs recurred 6–20 months after surgery. In the present study, because the surgical 
technique has only recently been developed, median follow-up time was 6 months, range 
0.5–29 months. Therefore, recurrence of clinical signs in some of the horses classed as 
successes in this study is still possible. Recurrence of signs may be due to nerve regrowth 
or it may be that some individuals had not been exposed to their trigger factors in the time 
between surgery and follow-up. 
This study defines success as being a substantial improvement, the criteria also chosen for 
previous studies (Mair 1999; Newton 2000; Madigan and Bell 2001). However, the ideal 
situation would be complete resolution and this should be considered in future studies. It is 
suggested that further refinement of surgical techniques is likely to be required to result in 
complete resolution of signs for a majority of horses. 
Reasons for a lack of response to surgery are likely to include misdiagnosis, failure to target 
the nerve in a sufficiently proximal location or migration of the coils allowing a greater than 
desired conduction of impulses along the nerve to persist following surgery. Coil migration 
was detected in all horses in which a first surgery had failed, and some of these horses went 
on to have a successful outcome from a repeat of the procedure. However, horses in which 
surgery was successful have not been routinely radiographed post operatively. Therefore, it 
is possible that there is coil migration in these cases also and that it does not affect success. 
For this reason, routine post-operative radiographs are recommended to assess coil 
positioning in all future cases. However, radiography provides a 2-dimensional image only, 
with which it is impossible to determine that the entire lumen of the infraorbital canal is filled. 
For this reason, computed tomography of the head is probably the best assessment of coil 
positioning. This would aid in determining its relationship with outcome from surgery. 
A possible cause of failure is that the stimulus to headshake might originate in the TgN in a 
more proximal location than the surgical site or within the ophthalmic or mandibular 
branches of the nerve. A majority of techniques in man target the nerve as it enters the 






or near its ganglion in the horse must be developed. We have not been able to access the 
nerve in such a proximal location due to the anatomy of the equine skull. However, a new 
technique of intracranial endoscopy to access the trigeminal nerve ganglion is being 
pioneered in man (Mourgela et al. 2007) and may allow access to the root entry zone and 
ganglion of the horse in the future. 
The most frequent post-operative complication was self-trauma to the nose. This is the same 
situation as for infraorbital neurectomy (Mair et al. 1992; Mair 1999). Prevalence of this 
complication in the present study was 45.8% cases, lasting 3–150 days. This is similar to the 
situation in Mair’s study (1999) where prevalence of this complication was at 84.2%, with 
signs lasting 21–56 days. It is likely that while the nerve is degenerating in response to 
pressure from the coils, an irritant stimulus is produced. Human patients that have had 
destructive surgery of the TgN for trigeminal neuralgia commonly report a burning, aching 
pain post operatively (Zakrzewska 2006) and this may be the stimulus for self-trauma in 
horses. Newton (2000) reported 5 cases of sclerosis of the posterior nasal nerve. This was 
effective in significantly reducing headshaking but only for 6 weeks to 9 months. However, 
none of these horses exhibited self-trauma. It may therefore be possible to avoid the side 
effect by performing sclerosis concurrently with coil compression. If the nerve was sclerosed 
at a site posterior to the position of the coils, then any irritant sensation during development 
of pressure necrosis may not be transmitted. 
Veterinary clinical studies are often limited by small sample size, as in this study. Even within 
the small number of cases there are many confounding variables. Furthermore, retrospective 
studies are limited by reliance on the scope of clinical records. Telephone follow-up from 
owners and referring veterinary surgeons, who are not blinded to the severity of the horse’s 
previous clinical signs, may result in an element of bias. Future studies should aim to follow 
a larger number of cases over a longer period. Ideally, determination of success should be 
based on a quantitative assessment of performance, such as winnings, although this is 
difficult to achieve in a pleasure horse population. A larger sample size of cases that had all 
undergone the same surgical technique would allow statistical analysis between outcome of 
surgery and findings from anamnesis and clinical investigations at presentation. 
Despite the limitations of these data, this study suggests that a substantial improvement in 
clinical signs of headshaking can be expected following this procedure. Further refinement of 
the technique is required in order to achieve total resolution in more individuals, to reduce 
the number of cases requiring revision of the surgery, and to reduce the prevalence and 
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Summary 
Reasons for performing study: Idiopathic headshaking is often a facial pain syndrome, but 
a diagnostic protocol has not been described. In a previous study, caudal compression of the 
infraorbital nerve for treatment offered a fair success rate, but low case numbers and short 
follow-up time were limitations. 
Objectives: To describe a diagnostic protocol for headshaking, examining the role of 
bilateral local analgesia of the posterior ethmoidal nerve (PET block). To report longer-term 
follow-up after surgery of the original cases and further cases and to determine whether 
changes to the technique influence success rates and complications. 
Methods: Records of horses that had undergone PET block and caudal compression 
surgery at 3 hospitals were reviewed. Modifications to the surgical technique included 
placing additional coils into the infraorbital canal and/or performing concurrent laser cautery 
of the nerve. Follow-up information was obtained by telephone contact with owners. 
Results: The PET block was performed in 27 horses, with a positive result in 23 of 27 
(85%). Surgery was performed in 58 horses. A successful outcome was initially achieved in 
35 of 57 (63%) horses, but recurrence occurred between 9 and 30 months later in 9 (26%). 






response to the last performed surgery, was 28 of 57 (49%) horses with median follow-up 
time of 18 months (range 2–66 months). Nose-rubbing was reported post operatively in 30 of 
48 (63%) horses. This resolved in all but 4 horses, which were subjected to euthanasia. 
Response to PET block or change in surgical technique did not appear to influence outcome 
or complications. 
Conclusions and potential relevance: The diagnostic protocol described is recommended 
for the investigation of headshakers. Caudal compression offers the best prognosis fora 
successful outcome compared with other treatments, for horses in which the only alternative 
is euthanasia. Surgical treatment of the disorder requires refinement, and the pathogenesis 
of the disorder requires investigation. 
Keywords: horse; headshaking; trigeminal neuropathy; facial pain; nerve compression 
Introduction 
There is mounting evidence that in many horses, idiopathic headshaking is a facial pain 
syndrome, probably due to a trigeminal neuropathy [1–8]. Although the pathophysiology of 
the disease remains unknown, some progress has been made towards both diagnosing and 
treating the condition [1,3,4]. 
A diagnosis of idiopathic headshaking is supported when no defined aetiology can be found 
on clinical examination. Typically, examination includes clinical assessment and observation 
of behaviour, oral examination, ophthalmic examination, skull radiography and endoscopy of 
the upper respiratory tract, including guttural pouches. Examination may also include more 
advanced imaging modalities, such as computed tomography (CT) of the head or 
scintigraphy. A diagnosis of idiopathic headshaking may still be reached when a possible 
cause is detected, but when this is treated successfully there is no resolution of 
headshaking. In a study of 100 headshaking horses, Lane and Mair [9] found a putative 
primary cause in only 4 individuals. Following treatment of these abnormalities, headshaking 
signs were resolved in only 2 cases. In another report of 5 horses, fungal sinusitis was 
suspected to be the underlying cause for headshaking, but the mechanism was still 
considered to be via a trigeminal neuropathy [8]. Although it appears likely that the majority 
of idiopathic headshakers do suffer from a facial pain syndrome, any diagnosis reached by 
exclusion may be considered inconclusive. Indeed, the absence of a conclusive diagnostic 
test has been a major obstacle to the acceptance by clinicians, horse-owners and insurance 






Diagnostic local analgesia is a well-established and accepted method to localise the source 
of pain in equine orthopaedic examinations and can be used to aid in diagnosis of trigeminal 
neuropathic pain. Bilateral local analgesia of the rostral portion of the infraorbital nerve (at 
the infraorbital foramen), albeit simple to perform, did not appear useful for diagnosis [4]. 
Bilateral posterior ethmoidal nerve analgesia (PET block) proved more useful for diagnosis, 
with 13 of 17 (76%) horses showing a positive response [4]. In the present study, we 
reviewed results from PET block in further individuals and consider whether response to 
PET block can be used as a prognostic indicator for likely response to surgery (caudal 
compression of the infraorbital nerve). 
The technique of caudal compression of the infraorbital nerve using intravascular coils for 
the treatment of idiopathic headshaking was first described in 2009 [1]. With a median time 
to follow-up of 6 months, 13 of 22 (59.0%) horses were considered by their owners to be 
significantly improved following a single surgery. Low patient numbers and short median 
follow-up time were major limitations of that first study. The present updated study reports 
longer-term follow-up of the original horses and 36 further cases. 
Materials and methods 
The clinical records of horses that had undergone caudal compression of the infraorbital 
nerve at 3 referral hospitals (The Philip Leverhulme Equine Hospital, University of Liverpool; 
The Royal Veterinary College; and Specialistdjursjukhuset Häst Strömsholm) between June 
2004 and January 2011 were reviewed. 
Historical data recorded included the situation in which the horse showed signs consistent 
with the syndrome (in the stable, at pasture, on the lunge and ridden). Where horses had a 
history of headshaking of more than 12 months’ duration, seasonality of signs was defined 
as either seasonal or nonseasonal. 
Comprehensive investigations to determine the cause of headshaking were carried out at 
the referral hospitals or by referring veterinary surgeons. This included a general clinical 
examination, dental examination and ophthalmic examination. The skull was imaged either 
through CT or radiography at exposures suitable for viewing the roots of the cheek teeth and 
sinuses. Endoscopy of the upper respiratory tract and guttural pouches was performed 
routinely. 
The majority of horses were observed to headshake during hospitalisation. A small number 
had only been observed to headshake by the referring veterinary surgeon, and the owners 






PET block was performed on all horses, unless precluded on the grounds of temperament. 
These horses were then reassessed in the same conditions. 
A bilateral PET block was performed following the technique described by Newton et a!. [4] 
(Figs 1, 2), but with the addition of mild sedative premedication with xylazine (Virbaxyl 10%)a 
(0.2–0.5 mg/kg bwt i.v.) to facilitate the procedure. Bilateral 3 - 4 cm areas ventral to the 
zygomatic arch were clipped and aseptically prepared. Mepivacaine (Intra-epicaine 2.0%)b 
(0.5 ml) was injected subcutaneously either below the transverse facial artery or between 
this artery and the zygomatic arch, depending on individual anatomical variation in the 
location of the facial artery. A 70 mm x 0.9 mm spinal needle was inserted in a rostroventral 
direction towards the upper sixth cheek tooth. The stylette was then removed and 5 ml 
mepivacaine injected and the needle withdrawn. Effects on headshaking were assessed 
once signs of sedation had resolved at 30 min, and then at 1 and 1.5 h. 
 
Figure 1: Technique for caudal anaesthesia of the infraorbital nerve. 
 






Surgery was performed in these horses, which were all diagnosed with a trigeminal nerve 
facial pain syndrome by a positive response to bilateral PET block without other mitigating 
pathological findings, or with idiopathic headshaking diagnosed by exclusion. Cases had 
previously undergone conservative treatments, such as use of a nose net, which were 
unsuccessful, and euthanasia was the only other option under consideration by the owners 
for these horses. 
The surgical technique as described by Roberts et al [1] was used, which involved the 
placement, under fluoroscopic guidance, of platinum embolisation coilsc (40 mm x 6 mm 
platinum embolisation coil) within the caudal portion of the infraorbital canal via the maxillary 
foramen in order to compress the nerve. In an attempt to improve outcome, a few 
modifications were applied to this technique in later cases. These involved increasing the 
number of coils deposited within the canal and the use of laser cauterisation of the nerve. 
For the latter modification, following insertion of the coils a diode laser fibre was introduced 
into the canal via an empty stylette, until the tip of the laser could be imaged just beyond the 
end of the stylette. The laser was activated for 2 periods of 0.1 s, at 25 W. Peri- and post- 
operative management was as described by Roberts et al [1]. 
Details of any post-operative complications were recorded. Follow-up information was 
obtained by telephone interview with the owner. As previously [1], the outcome of surgery 
was classified as successful if the horse was considered by the owner to be significantly 
improved. Most horses could not safely be ridden prior to surgery, and for these, outcome 
was classed as successful if they were back in ridden work. 
Results 
Fifty-eight horses met the selection criteria (34 at the University of Liverpool, 7 at The Royal 
Veterinary College and 17 at Specialistdjursjukhuset Häst Strömsholm). There were 16 
mares (28%) and 42 geldings (72%), with the most frequently represented breeds being 
Warmbloods (19 of 58; 33%) and Thoroughbred or Thoroughbred crosses (13 of 53; 22%). 
The most common use was general riding (21 of 58; 36%) followed by dressage (13 of 58; 
22%). Median age at first presentation was 9 years; range 1–17 years. 
All horses were reported to have shown headshaking when at exercise, with 33 of 48 (69%) 
also showing signs at rest. Headshaking was known to be seasonal (spring and/or summer) 
in 16 of 48 (33%) horses. The PET block was performed in 27 cases, with a positive result in 






findings from the other investigations were consistent with idiopathic headshaking, as for 
those where PET block could not be performed. 
In the majority of horses (38 of 51; 75%) for which it was recorded, up to and including 4 
coils were placed into each infraorbital canal at the first surgery. There were 13 of 51(25%) 
horses in which between 5 and 8 coils were placed. Laser was used as an adjunct in 27 of 
58(47%) of first surgeries. 
Following first surgery, 30 of 48 (63%) horses were reported by their owners to have shown 
nose-rubbing, which resulted in significant self-trauma, and 4 owners reported increased 
severity of headshaking signs following surgery. This complication was observed to start 
between 2 and 5 days after surgery. Administration of acepromazine (0.15 mg/kg bwt per os 
every 12–24 h) and/or gabapentin (2.5 mg/kg bwt per os every 12 h) was reported by some 
owners to reduce signs. In most cases, owners reported the complication to have resolved 
gradually by 4 weeks following surgery. There were, however, 4 horses that required 
euthanasia, between 2 and 5 months after surgery, owing to non-resolution and/or severity 
of this complication. 
A successful outcome from the first surgery was achieved in 35 of 57 (63%) horses, with one 
being excluded from analysis owing to being rested from work for other problems. However, 
signs of headshaking then recurred in 9 of these 35 (26%). The median length of time until 
relapse of the condition was 9 months (range 2–60 months). Of the horses that relapsed, 4 
were known to have seasonal headshaking. Median time to relapse for these horses was 
10.5 months (range 9–30 months). 
Surgery was repeated in 10 of 31 (32%) horses where the first surgical procedure had failed 
or the condition had recurred. There was a successful outcome in 5 of 8(63%) of these, with 
2 being excluded because of being out of work due to other problems or being lost to follow-
up. Of these 5, however, recurrence occurred in 3 individuals, of which 2 were known to 
have seasonal headshaking. Median time to relapse was 12 months (range 10–24 months). 
Surgery was performed for a third time in one seasonally affected individual, with signs 
recurring again at 12 months following the procedure. 
Final success rate, considering only response to the last performed surgery, was 28 of 57 
(49%) horses. Median follow-up time from the last performed surgery was 18 months (range 
2–66 months). The PET block had been performed in 27 cases, with a positive result in 23. 
These cases were fairly evenly split between surgical success (11 of 23, 3 of 4 respectively) 






Final success and failure were approximately evenly divided between horses that had up to 
and including 4 coils placed in each side at the first surgery (20 of 38, 53% success; 18 of 
38, 47% failure) and those which had between 4 and 8 coils per side placed at the first 
surgery (7 of 13, 54% success; 6 of 13, 46% failure). Final success and failure also 
appeared evenly divided between horses that had only coils placed and those where laser 
was used as an adjunct. Of 25 horses where it was known that only coils were placed, 15 of 
25 (60%) were successful, whereas when laser was used as an adjunct 15 of 31 (48%) 
cases were successful. Nose-rubbing postoperatively was recorded to have occurred in 14 
of 25 (56%) horses where only coils had been placed, and in 14 of 21 (67%) horses where 
laser was used. 
Discussion 
The rationale behind current therapies for headshaking is to limit input from the trigeminal 
nerve (TgN) or to reduce brainstem response to TgN input. Reported medical therapies 
include administration of cyproheptadine and/or carbemazepine, but results have been 
variable and short lived [4,5]. Nose nets have been reported to provide up to 70% relief, but 
only in 25% of cases [6]. Response to medical/conservative therapy is poor in most horses. 
This was the case for all the horses in this study, leaving no options other than trying surgery 
or electing for euthanasia. 
The first reported surgery for idiopathic headshaking was bilateral infraorbital neurectomy, 
performed rostral to the infraorbital foramina [3,10], with a success rate of3 of 19(15.8%). 
Failure of this technique may be expected if the stimulus to headshake originates within the 
trigeminal nerve branches in a more proximal site. Bilateral caudal nasal nerve sclerosis 
resulted in a 90–100% resolution of clinical signs in 5 of 5 horses [4], supporting a stimulus 
originating further distally, although the benefit was short lived. Caudal compression of the 
infraorbital nerve is currently the only surgical treatment for idiopathic headshaking that 
appears to result in a fair long-term success rate. 
Interpretation of the success rate is reliant upon the correct diagnosis. Horses were 
diagnosed either with idiopathic headshaking by exclusion, or with facial pain syndrome 
through use of a PET block. The PET block was used alongside a diagnosis by exclusion so 
that a positive response to local analgesia could be attributed to a trigeminal neuropathy 
rather than facial pain from other pathology. However, a diagnosis by exclusion may be 
considered unsatisfactory. Furthermore, the reliability and exact site of action of the PET 
block have not yet been established; it is likely that it is, in fact, the infraorbital nerve as it 






of local anaesthetic in this position. Some individuals with a negative response to PET block 
had a successful outcome from surgery. A successful outcome from surgery can be 
considered to confirm the diagnosis, so it is clear that the PET block is useful for diagnosis, 
but not conclusive. This is the case for all diagnostic local analgesia, where a false negative 
may be obtained in a number of situations, including misplacing the anaesthetic and in 
chronic or severe pain [11]. Accordingly, a positive response to PET block could not be used 
as a prognostic indicator for response to surgery. However, in the majority of cases, PET 
block was positive. It is, therefore, considered by the authors to be good practice to use the 
PET block in the investigation of headshakers, where headshaking signs are consistent and 
the horse is amenable to the procedure, as the most objective available measure of facial 
pain. 
The mechanism of action of caudal compression of the infraorbital nerve is unknown. 
Likewise, detailed understanding of the role of the caudal nasal nerve, a branch of the 
maxillary nerve from the trigeminal nerve, in the condition remains unclear. This nerve is 
responsible for most of the sensory innervation of the caudal nasal cavity and the paranasal 
sinuses, and its involvement in headshaking would seem to fit the observations, especially in 
horses that appear to have an inhaled trigger factor. Anatomical variation suggests that in 
some 30% of horses the site of coil deployment, as in the current technique, would be rostral 
to the origin of the caudal nasal nerve from the maxillary nerve (personal communication, J. 
D. Perkins), and this could be a potential cause for failure. Logically, we would suspect that 
the degree of compression inflicted on the nerve would be greater if more coils were used, 
and greater nerve damage might result if laser cautery was used, and we would therefore 
speculate that these modifications might increase successful outcomes. Percutaneous 
balloon compression of the trigeminal nerve at the level of the trigeminal ganglion against 
bone is a similar procedure used for the treatment of trigeminal neuralgia in man, and in 
these cases success is correlated to the severity of nerve damage [12]. However, this has 
not been replicated in our procedure. Where horses either did not respond to the first 
procedure or relapsed, some benefited from a repeat procedure. In the majority of these 
cases, this ultimately resulted in 8 platinum coils being present within each infraorbital canal. 
However, despite this repeat procedure sometimes producing a positive result, there was no 
greater success rate obtained at the first procedure if a greater number of coils were 
implanted initially. This would suggest that the mechanism of action of the surgery may 
simply be the nerve damage arising from performing the procedure, rather than the number 
of coils that were used. Histopathology or electron microscopy of the infraorbital nerve 






unsuccessful outcome, is required to improve understanding of the mechanism of action of 
this procedure. 
Post-operative nose-rubbing with possible self-trauma and increased severity of 
headshaking was reported in 63% of horses, a slightly lower incidence than reported 
following bilateral infraorbital neurectomy (84%) [3,10]. There appeared to be no proportional 
risk from the number of coils placed or the use of laser on this side effect, but case numbers 
are insufficient for statistical analysis. Following surgical techniques for treatment of 
trigeminal neuralgia, some human patients report a burning ‘pins and needles’ (neuropraxia) 
sensation in the face, and it is possible that these horses are experiencing a similar 
sensation. Although in most cases these unpleasant side effects were short lived, 4 horses 
had to be subjected to euthanasia owing to their severity and/or nonresolution. It is for this 
reason that the authors advocate that caudal compression of the infraorbital nerve should 
only be used as a treatment for headshaking in cases after conservative treatments have 
failed and where the only alternative is euthanasia. 
Caudal compression of the infraorbital nerve resulted in an initial success rate of 63%. As in 
the previous study [1], the assessment of success is based on a subjective owner opinion, 
which required the horse to be significantly improved and not necessarily completely free of 
clinical signs. About one-quarter of cases showing an initial improvement may be expected 
to relapse based on our results. It is relevant to consider the effect of seasonal headshaking 
on these figures, which may influence apparent amelioration of the signs if coincidental with 
surgery. Distinguishing between a case where surgery did not alter signs, which then 
returned seasonally, and one where there was initial improvement followed by relapse after 
some months could prove challenging. Although this may have been the case in some 
individuals, the long follow-up period, including those where the time taken to relapse was up 
to 30 months following the procedure, suggests that misinterpretation of the outcome due to 
seasonal effects was not likely in most cases. The cause for relapse of clinical signs is 
unknown, but our outcomes are remarkably similar to those reported after percutaneous 
balloon compression for trigeminal neuralgia in humans, where 15–22% relapsed at 3 years 
[13,14]. 
In conclusion, caudal compression of the infraorbital nerve currently appears to be the best 
available treatment for idiopathic headshaking due to trigeminal neuropathy in horses for 
which the only alternative is euthanasia. The surgical treatment of the disease clearly 
requires refinement and improvement. However, even in human trigeminal neuralgia there is 






completely relieves signs with consistent long-term results and without side effects [15]. It is 
imperative that we continue to investigate the aetiopathogenesis of this pain syndrome in 
order to develop improved medical and surgical therapies. Headshaking remains a 
significant cause of distress for some horses, which justifies the application of this treatment 
in selected cases even though the failure rate is finite. 
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Chapter 6: Treatment 
Development of percutaneous electrical nerve stimulation as a neuromodulatory 
treatment in horses 
6.1 Candidate contribution for Papers Six and Seven 
The concept of Paper Six was shared equally between the first and second authors. All 
authors contributed equally to study design. I obtained ethical permission and funding from 
the Langford Trust for Animal Health and Welfare. Execution of the study was mostly by 
myself with contribution by the last author, as was data analysis. Preparation of the 
manuscript was largely by myself, with all authors inputting into and approving the final 
version. 
For Paper Seven, the concept was mine. I made the most contribution to study design, with 
input from the second and last authors. I sourced ethical permission. I secured an Inspire 
(Academy of Medical Sciences and the Wellcome Trust) studentship award to support this 
project, whilst introducing a veterinary undergraduate to basic research concepts. Study 
execution was by myself and all members of the EquiPENS™ Group in their respective 
institutions. Data analysis was by the second author with my contribution. I prepared the 
manuscript with input from some members of the EquiPENS™ Group and the final version 
was approved by all authors.  
6.2 Paper Six 
Neuromodulation using percutaneous electrical nerve stimulation for the management of 
trigeminal-mediated headshaking: A safe procedure resulting in medium-term remission in 
five of seven horses. 
Roberts V.L.H., Patel N.K., Tremaine W.H. 
Equine Veterinary Journal 2016 ISSN 0425-1644 DOI: 10.1111/evj.12394 







Neuromodulation using percutaneous electrical nerve stimulation for the management of 
trigeminal-mediated headshaking: A safe procedure resulting in medium-term remission in 
five of seven horses. 
Roberts V.L.H., Patel N.K.1, Tremaine W.H. 
Bristol Vet School, University of Bristol, Langford House, Langford, North Somerset 
1. Institute of Neurosciences, Southmead Hospital, Bristol 
Summary 
Reasons for performing study: There are no consistently safe and effective methods for 
the treatment of trigeminal-mediated headshaking in horses. In affected horses, the 
trigeminal nerve is sensitised, appearing to result in neuropathic pain. Percutaneous 
electrical nerve stimulation (PENS) therapy is a minimally invasive neuromodulatory 
treatment used in people to manage neuropathic pain. 
Objectives: To determine whether PENS therapy is safe, tolerated and effective for the 
management of trigeminal-mediated headshaking in horses. Study design: Descriptive case 
series. 
Methods: Seven horses diagnosed with trigeminal-mediated headshaking and currently 
showing clinical signs were studied. All procedures were carried out in sedated horses with a 
needle-prick sized area of skin desensitised with local anaesthetic to facilitate probe 
insertion. A disposable PENS probe was advanced subcutaneously adjacent to the nerve, 
rostral to the infraorbital foramen under ultrasonographic guidance. The nerve was 
stimulated for 25 min following a protocol of alternating frequencies and a perception 
threshold based on human clinical data. The probe was removed and the procedure 
repeated on the contralateral side. The protocol used comprised a series of 3 or 4 
treatments, with treatments being repeated when signs of headshaking recurred. 
Results: All horses tolerated the procedure well. Three horses developed a haematoma at 
the site on one occasion and 2 had increased clinical signs for up to 3 days following first 
treatment. Six horses demonstrated a positive response to their first treatment, returning to 
ridden work at the same level as prior to onset of headshaking, with 5 continuing to respond. 
Median remission time for first treatment was 3.8 days (range 0–8 days, n = 7), second 
treatment 2.5 weeks (0–8 weeks, n = 7), third treatment 15.5 weeks (0–24 weeks, n = 5) and 






Conclusions: Percutaneous electrical nerve stimulation therapy is a safe, well tolerated, 
minimally invasive, repeatable management option for trigeminal-mediated headshaking, 
with encouraging efficacy for amelioration of clinical signs in the short- to medium term. 
Keywords: horse; headshaking; trigeminal-mediated; neuromodulation; percutaneous 
electrical nerve stimulation PENS 
Introduction 
At present, there are no consistently safe and effective methods for the treatment of 
trigeminal-mediated headshaking in horses. Treatments include the use of a nose-net which 
improves clinical signs by 70% or greater in one-third of horses [1], medication including 
carbamazepine and cyproheptadine [2–4] that has inconsistent results and is associated 
with high cost, possible side effects of drowsiness and governing sport federation prohibition, 
and surgical treatment by compression of the infraorbital nerve using platinum coils which 
has been reported to have an approximate 50% success rate [5]. Side effects sufficiently 
severe as to result in euthanasia occurred in 4 of 58 horses and thus this procedure is 
recommended only in cases where euthanasia is the only alternative [5]. 
Advance in treatment for trigeminal-mediated headshaking is undoubtedly hampered by our 
incomplete understanding of the aetiopathogenesis of headshaking. However, 
somatosensory-evoked potentials have demonstrated the trigeminal nerve of affected horses 
has a reduced threshold for activation [6]. This sensitisation appears to result in neuropathic 
pain. 
Percutaneous electrical nerve stimulation (PENS) therapya is a repeatable, minimally 
invasive neuromodulatory therapy which may be used under National Institute for Health and 
Care Excellence (NICE) guidelines [7] for the management of neuropathic pain in people. A 
disposable probe is placed subcutaneously perineurally and a previously derived protocol of 
electrostimulation is applied with the aim to decrease the sensitivity of the target nerve [8]. 
Side effects reported include temporary bruising at the site of probe insertion and a few 
individuals reported a slight increase in pain in the short term, although may still go on to 
experience relief from pain [7]. The NICE guidelines advise that the procedure is repeated 
when symptoms resume. Anecdotally, the desensitisation following the initial procedure may 
last from a few hours to several days and, after the second treatment, remission may last a 
few days up to 2 weeks and remission following the third treatment may last about 3 months. 
The duration of remission following the third treatment is usually the maximum attained and 






human trigeminal neuropathic facial pain has been predominantly for patients suffering 
neuropathic pain secondary to radical surgery and/or radiotherapy for cancers of the head 
and neck. In a small study of 8 such patients with refractory neuropathic trigeminal pain [9], 
7/8 patients reported significant pain relief immediately after treatment. The minimum 
duration of pain relief was 14 days and the maximum was ongoing at 175 days at the time of 
follow-up. Treatments were repeated when pain returned, with the procedure being well 
tolerated. In another randomised, double-blind, sham-controlled crossover study of 31 
patients with surface hyperalgesia, median numerical rating scale for neuropathic pain 
changed from 7.5/10 before treatment to 0.5/10 with a follow-up time of one week [10]. 
Our hypothesis was that minimally invasive neuromodulation using PENS therapy of the 
maxillary branch of the trigeminal nerve may be a safe, well tolerated, repeatable therapy to 
manage neuropathic pain in trigeminal-mediated headshakers in the short- to medium term. 
Materials and methods 
Horses 
Eligible cases were trigeminal-mediated headshakers referred to the University of Bristol’s 
Langford Veterinary Services Equine Centre between August 2013 and August 2014. 
Horses included were displaying clinical signs at the time of first treatment and did not, or 
were not known to, show complete seasonal remission. In all cases, the diagnosis of 
trigeminal-mediated headshaking was made following a standard diagnostic protocol that 
included history, observation, clinical examination, diagnostic local anaesthesia around the 
caudal portion of the infraorbital branch of the maxillary nerve in the pterygopalatine fossa, 
computed tomography of the head, oral examination, ophthalmic examination and 
endoscopy of the upper respiratory tract including guttural pouches. The severity of 
headshaking was graded following a 0–3 point scale, with 0 being asymptomatic, 1 
described as headshaking only at exercise and sufficiently mild that the horse may be 
ridden, 2 being headshaking at exercise to a severity as to make ridden exercise unsafe or 
impossible and 3 being headshaking at rest as well as at exercise [11]. They could have 
previously received, but responded insufficiently to, other treatments for headshaking but 
horses which had undergone coil compression surgery would be unsuitable candidates for 
neurostimulation due to the presence of implants. Where horses had received other 









Following placement of an i.v. jugular catheter, horses were restrained in stocks. Sedation 
was with i.v. detomidine hydrochloride (Domidine)b at a loading dose of 10 mg/kg bwt and 
was maintained by i.v. infusion at 0.025 mg/kg bwt/h. Two 5 x 5 cm squares were clipped 
over the infraorbital foraminae and a 10 x 10 cm square over the shoulder area for the 
grounding pada. On each side, 2 cm caudo-dorsal to each infraorbital foramen, 0.25 ml of 
2% mepivacaine hydrochloride (Intra-epicaine)b was injected subcutaneously using a 0.64 x 
25 mm needle in order to facilitate probe placement. The small volume was used to reduce 
the risk of anaesthetising the infraorbital nerve. The skin in this anaesthetised region was 
perforated with a 1.6 x 38.1 mm hypodermic needle. A disposable 50 x 0.75 mm electrically 
conductive PENS therapy probea was inserted percutaneously through the incision in a 
diagonal rostro-ventral direction (Figure 1). Ultrasonographicc guidance was used to direct 
the probe approximately 1 mm superficial to the infraorbital nerve. The NeuroStimulator 
PENS therapy devicea was connected to the grounding pad and probe. After a standard test 
stimulation (to check equipment function and tolerance of the horse), the nerve was 
stimulated at 2 and 100 Hz alternating every 3s for a period of 25 min at voltages ranging 
from 0.2 to 2.7 volts (V). The device is voltage-controlled with the current delivered varying in 
line with potentially varying impedances encountered (such as distance of placement from 
the nerve fibres) and being set by the patient’s response of twitching of the facial muscles 
within their tolerance level for the procedure. A video is available as supplementary online to 
this paper. Treatment prescribes that the current perception level be maintained throughout 
the procedure by increasing or decreasing the voltage. The stimulation was started at 0.2 V 
and gradually increased in 0.1 V increments (at both frequencies) to a voltage sufficient to 
stimulate this twitching of the facial muscles but within the tolerance level of the individual 
horse. As time elapsed during each procedure, the maximum voltage tolerated could usually 
be increased to maintain the same effect. The procedure was then repeated on the 
contralateral side. Horses were able to be discharged from the hospital on recovery from 
sedation and owners were advised to return them to normal management and ridden work 
from the following day and to report back on their progress. Procedures were repeated as 







Figure 1: Horse with PENS probe in situ during electrostimulation. 
Results 
































1 7 Thoroughbred G Point-to-point 
racing 
3 Improves to 
grade 2/3 in 
Winter 
2 14 Irish Sports Horse G Riding club 
activities 
3 Improves a little 
in Summer but 
remains grade 
3/3 
3 4 Thoroughbred M Riding club 
activities  
2 Not known 
4 11 Cob G Riding club 
activities 
3 None 
5 6 Polish Warmblood G Riding club 
acitivities 
3 Not known 
6 11 Irish Draught cross G Riding club 
activities 
2 None 
7 5 Pony M Eventing 2 Not known 
Table 1: details of horses used in the study. 
All horses were displaying clinical signs at the time of enrolment on the trial. Severity of 
headshaking was graded at least as 2/3. One horse (Horse 1) was reported to have a history 
of showing milder clinical signs through the winter months and one (Horse 2) milder signs 
through the summer months although, even during periods of improvement, they remained 
significantly affected with their signs then graded 2/3 and 3/3, respectively. For 3 horses, 
seasonal variation in signs was unknown, having presented with clinical signs of fewer than 
6 months’ duration. Most horses had previously received and responded insufficiently to one 
or more recognised treatments for headshaking but none had undergone coil compression 
and no other treatments had been used for at least one month prior to neurostimulation. 
A total of 24 bilateral procedures were carried out on the 7 horses over the study period 
(August 2013 to August 2014). Further details of the individual procedures are recorded in 
Table 2. The stimulation resulted in facial muscle twitching throughout the procedure on all 
treatments bar one (Horse 2, second treatment). In that horse the procedure did not result in 
remission of clinical signs, although the 3 other procedures which did cause twitching in the 









HORSE Duration of 
remission (0/3 












or 1/3) from 4th 
treatment  
Adverse effects / 
comments 




Still in remission 
at 4 months when 
pasture rested 
due to other 
problems 
N/A Haematoma at first 
treatment. 
Slight increase in 
clinical signs for 2 
days following this 
treatment 
2 4 days None 2 months Ongoing at 7 
months 
No twitching induced 
by 2nd treatment 
3 8 days 4.5 weeks 3.5 months with a 
gradual return of 
clinical signs 
In remission at 
12 weeks when 
rested due to 
orthopaedic 
injury 
Slight increase in 
clinical signs for 3 
days after 1st 
treatment. 
Haematoma at 2nd 
treatment. 
4 12 days Still in 
remission at 8 
weeks when 
rested due to 
fracture 




at 5 weeks 
5 3 days 2.5 weeks Ongoing at 6 
months 
N/A  
6 0/3 for 3 days None None N/A Haematoma at 1st 
treatment 
7 None None None N/A  
Table 2: Details of procedures and responses. 
All horses tolerated the procedure well. Three horses developed a haematoma at the site on 
one occasion and 2 showed a slight increase in clinical signs for up to 3 days following first 
treatment. 
Owners reported on their horse’s progress with data provided being whether or not the horse 
was back in ridden work at the level prior to onset of headshaking, the presence and severity 
of any signs when ridden and at rest and, where applicable, a competition record. The 
criterion for success was a return to ridden work at the level prior to the onset of 
headshaking. Details are recorded in Table 2. Videos are available as online supplementary 
information to this paper, of Horse 6 before and 3 days after his first treatment and Horse 5 
before starting treatment, 10 days and 15 weeks after the third treatment. 
Six horses showed remission of clinical signs after the first treatment, returning to ridden 
work at their previous level, with 5 continuing to respond to further treatments. Median 
remission time for first treatment was 3.8 days (range 0–8 days, n = 7), second treatment 2.5 
weeks (0–8 weeks, n = 7), third treatment 15.5 weeks (0–24 weeks, n = 5) and fourth 
treatment 20 weeks (12–28 weeks n = 2) with one of these horses still being in remission at 






Horse 1 returned to race training but following a severe respiratory tract infection 4 months 
after his third treatment he was pasture-rested until the next point-to-point season so has yet 
to be returned to work and be fully assessed, as the criterion for success for this study was 
return to ridden work. For the purpose of this study, his remission time has been recorded as 
4 months. However, it was reported that while the presence of clinical signs at exercise 
could no longer be tested, this horse remained free of clinical signs when in the field at 
follow-up 7 months following his third treatment; a time of year when he displayed clinical 
signs pre-treatment during turnout. 
Horse 3 sustained an orthopaedic injury 12 weeks following the fourth treatment, at which 
time she was still in remission. Again, as the criterion for success was return to ridden work, 
for the purposes of this study remission time was recorded as 12 weeks. During periods of 
remission, the owner reported this horse to be grade 0/3 or grade 1/3 for the majority of the 
time but she had occasional days at 3/3 and benefited from the use of a nose-net. 
Horse 4 showed total remission following 2 treatments and was still free of clinical signs of 
headshaking 8 weeks after the second treatment at which point he was box-rested due to an 
orthopaedic injury. It was deemed not possible to assess him comparatively thereafter. Four 
months after the injury, he returned to turnout and work at which time signs of headshaking 
returned. This horse re-started the treatment course with the first and second treatments 
being administered 6 days apart. While we can report his response to be ongoing remission 
at 5 weeks, we have excluded results from this second treatment course in our descriptive 
statistics. Horse 6 showed a period of total remission following the first treatment but then 
failed to respond to the second or third treatments. Horse 7 did not respond to any of the 3 
treatments. 
Discussion 
There is a strong clinical need for a safe, effective and sustainable treatment for trigeminal-
mediated headshaking. These results suggest that PENS is safe and effective and can 
achieve medium-term control of clinical signs in some cases, even if a permanent cure 
remains elusive. 
With current therapies for headshaking, medium- to long-term prognosis for horses to 
continue as athletes is guarded [12]. The results from this pilot study are very encouraging 
especially if they are reproduced when used in a greater number of cases. Successful 
control of trigeminal neuropathic pain in people is likely to vary depending on the cause of 






headshaking before prescribing PENS therapy and to select patients carefully for recruitment 
to PENS. The best diagnostic investigation for case selection would include a diagnosis of 
sensitisation using somatosensory-evoked potentials as this therapy is applicable mainly to 
sensitised peripheral nerves, although the practical feasibility of this is limited as it requires 
general anaesthesia [12]. A key feature of diagnosis in the cases in this study was response 
to diagnostic local anaesthesia around the region of the caudal portion of the infraorbital 
nerve. Treatment is directed rostrally to this, which may confound efficacy, although where 
twitching is induced one may assume the nerve stimulation impulse has travelled the length 
of the nerve. 
As is the case with human patients, we have been unable to achieve a 100% success rate. 
Further knowledge about the aetiopathogenesis of trigeminal-mediated headshaking and the 
mechanism of action of neurostimulation would help us to better understand what makes a 
treatment successful and why one has failed, which is perhaps of particular interest in those 
cases where response has been inconsistent. There are many limitations to merely 
transferring a treatment and protocol used in people directly to horses and further knowledge 
of both trigeminal-mediated headshaking, how that compares with human neuropathic facial 
pain syndromes and the mechanism of action of PENS neurostimulation could allow for a 
more targeted approach. There is an important role in further work to not only expand 
numbers but to refine the treatment protocol specifically for treatment of headshaking 
syndrome in horses; alternation and strength of voltage and frequency, duration of 
stimulation and interval between treatments. 
National Institute for Health and Care guidelines [7] state that better results can be expected 
as the operator’s experience in probe placement increases. Subjectively, we found the 
number of attempts required to place the probe in the correct position as judged by 
ultrasonography, markedly decreased through the study. It appears important for the 
stimulation to result in twitching, which is interpreted as evidence of appropriate nerve 
stimulation by our experiences gained during the study. Hence it is probable that the therapy 
will be more successful when performed by an experienced operator. 
In addition to its efficacy, there are other factors upon which the success of this treatment is 
measured. Our criterion for a successful outcome is to enable the horse to return to ridden 
exercise at the same level at which it was ridden prior to the onset of headshaking [5]. 
Remission of signs to allow ridden work requires remission to grade 0/3 or grade 1/3. 






the horses in this study were used for affiliated level dressage and this would be a greater 
test of success. 
There must also be a practical duration of treatment benefit for a management intervention 
to be useful. We consider owner compliance to be unlikely if the duration of remission of 
clinical signs after the primary course of 3 treatments is less than 2 months. In human 
medicine, where there is good response to PENS, patients may be considered for 
permanently implanted devices [7]. While this may be technically feasible in horses, it is 
unlikely to be a practical option financially or in horses competing under the rules of sport 
governing bodies (e.g. Fédération Equestre Internationalé) so permanent implants are 
unlikely to have a future in competition horses, although leisure horses may have this 
possibility. 
The owners’ interpretation of successful treatment of headshaking syndrome is affected by 
the placebo effect [13]. We have reduced this risk in this study by applying an objective 
criterion of success, that being a return to ridden work in cases which were unsafe or 
impossible to ride previously [11], rather than a subjective assessment of an improvement of 
signs [13]. On 3 occasions in our study, owners judged PENS therapy to have been 
ineffective but had with previous or later treatments been able to return the horses to ridden 
work again. The ability of these owners to differentiate between successful and unsuccessful 
procedures acts as a type of internal control for the placebo effect. As used by Raphael et al. 
[10], a double-blinded sham-controlled crossover study of the efficacy of PENS 
neurostimulation would have much improved the merit of this study but was not practical at 
this early stage. 
A better attempt to quantify partial success of modification of signs might be useful in the 
future, to critically evaluate this and other therapies. The incomplete follow-up in some cases 
due to unrelated conditions and the inclusion of 3 cases where a history of seasonality was 
unknown may compromise our data. There is a risk that in the 3 horses with unknown 
seasonality there is an effect of season in the length of time of their remission; however, not 
in the fact each treatment resulted in initial remission as all horses were symptomatic at the 
time of the treatment. We will continue to collect data on all the horses in this study. 
The safety of the procedure is important, particularly in light of the morbidity of alternative 
treatments. For example, coil compression treatment, while effective in approximately 50% 
of cases, carries a serious risk of potentially fatal side effects [5]. None of the horses in this 
study experienced significant adverse effects, a finding we expected and is consistent with 






repeated, initially frequently and therefore it is important that it is well tolerated by a 
conscious horse. The procedure was tolerated well under standing sedation by all the horses 
in the study and anecdotally human patients report the procedure to give a pleasant 
sensation. However, we advise careful probe placement under ultrasonographic guidance as 
penetration of the nerve by a probe could result in an extreme reaction. 
Although it is clear that further work is required, including expanding the number of cases 
and refining treatment protocols, it is our opinion that, at present, PENS therapy should be 
considered as a first-line treatment for trigeminal-mediated headshakers which have failed to 
respond to conservative treatment such as nose-nets, at equine treatment centres with 
appropriate facilities and expertise. 
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Safety and efficacy of EquiPENS™ neuromodulation for the management of trigeminal 
mediated headshaking in 168 horses. 
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Summary 
Background: Early results from the use of neuromodulation by percutaneous electrical 
nerve stimulation for the management of trigeminal-mediated headshaking in horses were 
promising but lacked sufficient case numbers and long-term follow-up. The neuromodulatory 
procedure has since been established as EquiPENSTM. 
Objectives: The aim of this study was to report long-term results from a larger number of 
cases and to investigate for predictors of outcome.  
Study design: Prospective case series using international, multi-centre data. 
Methods: Eligible cases were horses with a veterinary diagnosis of trigeminal-mediated 
headshaking, which received EquiPENSTM neuromodulation at trained centres between 
August 2013 and November 2017. The standard protocol was an initial three-procedure 
course, with additional procedures should a horse go into remission but then relapse. Data 
collected included signalment, history, diagnostic tests performed, details of any 
complications, whether horses had gone into remission and the length of remission. 
Results: Results were obtained from 168 horses, with 530 procedures. The complication 
rate was 8.8% of procedures. In all but one case, complications were mild and transient, 
without self-trauma. Remission of headshaking following the initial course occurred in 53% 
(72/136) of horses. Median length of time recorded in remission was 9.5 weeks (range 2 
days to 156 weeks ongoing). Where signs recurred, most horses went back into remission 
following additional procedures, usually for longer than from the previous procedure. No 
predictors for outcome were determined.  
Main limitations: No placebo or control group, owner-assessed results. 
Conclusions: EquiPENSTM neuromodulation can be an effective and safe treatment for the 
management of trigeminal-mediated headshaking in some horses. An increased 






for trigeminal-mediated headshaking will remain limited until there is a greater understanding 
of the aetiopathogenesis of the condition. 
Keywords: horse; headshaking; trigeminal-mediated; neuromodulation; percutaneous 
electrical nerve stimulation 
Introduction 
Trigeminal-mediated headshaking is an idiopathic neuropathic facial pain condition of the 
horse. The condition can have important welfare implications [1]. It carries a poor prognosis, 
with published treatments lacking consistent efficacy, and in some instances, safety and 
practical application [2–5]. The use of a nose-net improves clinical signs by 70% or greater 
in one-third of horses [6]. A nose-net is non-invasive and cheap and is usually the first-line of 
treatment but its use in competition is not accepted by all equestrian organisations. Medical 
treatment with carbamazepine and/or cyproheptadine [2,7] can be effective in some 
individuals. However, in general, results are inconsistent, and the use of these 
pharmaceuticals can be expensive, associated with side effects of drowsiness and would not 
usually be permitted in competition. The surgical placement of platinum coils within the 
infraorbital canal was reported to have a 49% remission rate [5] but resulted in adverse 
effects of enough severity as to result in euthanasia in 4/58 horses. 
Advances in the treatment for trigeminal-mediated headshaking will remain limited until the 
aetiopathogenesis of the condition is understood. The most recent advance was that the 
trigeminal nerve of affected horses is sensitised, having a reduced threshold for activation, 
which is thought to result in neuropathic pain [8]. The nerve is functionally abnormal but 
appears to be structurally normal [9] which could mean that the sensitisation is reversible. 
Following on from this, percutaneous electrical nerve stimulation, a repeatable, minimally 
invasive neuromodulatory therapy with some application for the management of neuropathic 
pain in people, was trialled in seven horses [10]. All horses tolerated the procedure well. 
Three horses developed a haematoma at the site on one occasion and two had increased 
clinical signs suspected to be due to a transient neuritis, for up to 3 days following one of the 
procedures. All horses underwent a minimum of three procedures, with two horses having 
four procedures. Following their last procedure, remission, classed as ridden work at their 
previous level, was obtained in five horses, with a median remission time of 15.5 weeks from 
the third procedure and 20 weeks from the fourth. These early results were promising for 
management of the condition but lacked sufficient case numbers and long-term follow-up. 






equipment and technique, gave positive results in a small number of suspected trigeminal-
mediated headshakers [11]. 
The percutaneous electrical neuromodulatory procedure has since been established as 
EquiPENSTM and various centres across the UK and Europe have been trained by the first 
author in the technique, using the same equipmenta, ensuring consistency. The aim of this 
study is to report long-term results for treatment with EquiPENSTM and to identify any 
predictors for outcome from a larger number of cases, using international, multi-centre data. 
Materials and methods 
Eligible cases were horses with a veterinary diagnosis of trigeminal-mediated headshaking, 
which received EquiPENSTM neuromodulation at trained centres between August 2013 and 
November 2017. Centres were issued with guidelines for reaching a diagnosis of trigeminal-
mediated headshaking. These are detailed in Appendix Three. Horses could have previously 
received, but responded insufficiently to, other treatments for headshaking, but were not 
receiving any other treatment at the time of enrolment. In order to assess response to 
treatment, horses were in ridden or lunge work prior to the onset of clinical signs of 
headshaking. EquiPENSTM neuromodulation was performed as described previously [10]. 
The protocol was for each horse to receive an initial course of three procedures. The second 
procedure was performed 3–7 days after the first procedure, and the third procedure was 
performed 10–14 days after the second procedure. Intervals were extended if a horse went 
into remission after a procedure, until it relapsed. If the horse went into remission after three 
procedures but then relapsed, additional procedures could be performed. 
A standard recording form was available to each centre for prospective collection of data 
regarding each horse’s signalment, history and the diagnostic tests they performed. The 
information requested included whether signs were known to be spring/summer seasonal 
only or present all year round. Seasonality of signs was recorded as unknown in those cases 
which were reported to have been affected for less than a year. The diagnosis of trigeminal-
mediated headshaking was made by exclusion. If during investigation abnormalities were 
detected, these were judged to not be clinically relevant, sometimes after treatment with no 
response. Examples would include sharp dental arcades and iris cyst. 
Centres were also asked to record the following information for each EquiPENSTM procedure 
performed for each case: the date of the procedure; whether any complications were 
experienced during or after the procedure and the nature of those complications; whether 






ridden exercise (or if not trained, lunge exercise) at, or above, the level of performance prior 
to the onset of clinical signs, within 3 weeks from the last procedure. This was an 
assessment made by the owner. Follow-up on each case was obtained by the centre 
responsible for that case by telephone questionnaire (Appendix Four). The longest-term 
available follow-up was used in this study. Where horses had been initially classified as 
going into remission with an initial follow-up performed prior to March 2016, follow-up was 
repeated between July and November 2017. Where horses could no longer be classified as 
being in remission, whether this was due to recurrence of headshaking signs or because 
horses could no longer be assessed as they were out of ridden work for other reasons, was 
recorded. Otherwise, remission was recorded as being on-going at the time of follow-up. 
Data analysis 
Statistical analysis was performed using the survival and survminer packages for the R 
statistical program (Version 3.4.4)b and R Studio (Version 1.1.423)b running on Ubuntu 
17.10c. Censored survival objects were created using the Surv function of the survival 
package and Kaplan Meier plots created using the survfit and ggsurvplot functions. 
Probabilities for differences in length of remission after third or final treatment dependent on 
response to first or second treatments were calculated using log-rank methods. Cox 
proportional hazards for presence of and differences in length of remission dependent on 
management, centre and history prior to treatment were calculated using the coxph function. 
Variables tested were: the time for which the horse had been affected with clinical signs prior 
to presentation; whether use of a nose-net had, judged by the owner, no effect on clinical 
signs, insufficient effect or aggravated clinical signs; whether diagnostic local anaesthesia 
had been performed, the location of that anaesthesia and the result; seasonality. 
Results 
Population statistics 
There were 168 horses fitting the inclusion criteria. The median age at presentation was 9 
years (range 2–21 years, n = 163, 5 not recorded). The most common groups of breeds 
were sports horses (49/160, 31% 8 not recorded) and warmbloods (42/160, 26%). Age 







Figure 1: Age distribution across breeds. 
There were 120/165 (73%) geldings, 42/165 (25%) mares and 3/165 (2%) stallions. The sex 
of 3 horses was not recorded. Procedures were performed at 13 trained centres across the 
UK and Europe. On occasion, diagnostics and the first one or two procedures were 
performed at one centre, with other procedures performed at a different centre. In these 
instances, the first centre only was attributed the case. The distribution of cases across the 







Figure 2: Distribution of cases across centres. 
Most horses (94/166, 57%, 2 not recorded) were used for general riding. Distribution of use 







Figure 3: Uses of horses. 
Prior treatment 
Nose-nets had been trialled for treatment in 128 horses and it was reported by the owner to 
have no, or insufficient, effect in 109/128 (84%) cases and worsen clinical signs in 16/128 
(12%) cases. Three horses whose clinical signs were alleviated by use of a nose-net were 
presented for treatment because they were unable to compete in their discipline with a nose-
net. 
Distribution of the main other attempted treatments are shown in Figure 4. None of these 
treatments were reported by the owners to have been effective or sufficiently effective. Less 








Figure 4: Main prior attempted treatments in the study cases. 
Diagnosis 
All horses were diagnosed with trigeminal-mediated headshaking by veterinary surgeons. 
European or American board-certified specialists were responsible for case management at 
9/13 centres. The median length of time for which horses were affected prior to presentation 
was 4 months (range 0.5–84 months, n = 153, 15 not recorded). There were 21/158 (13%, 
10 not recorded) horses known to be Spring/Summer seasonally affected and 62/158 (39%) 
horses known to be affected all year round. Seasonality was unknown i.e. horses having 
been affected for less than a year, in 75/ 158 cases (48%). 
The diagnostic techniques performed included computed tomography of the head in 124/168 
(85%) cases (21 not performed, 23 not recorded). Diagnostic local anaesthesia was 
performed bilaterally at the caudal point of the infraorbital canal in 51 cases, giving a positive 
result in 35/51 (68%). Bilateral diagnostic local anaesthesia of the infraorbital nerve at the 
level of the infraorbital foramen was performed in a further three cases, giving a positive 
result in two cases. Diagnostic local analgesia was not performed in 79/133 (59%) cases. 
Procedure information 
A total of 530 procedures were performed. Of the 168 horses which began the initial three-
procedure course, 156 horses had completed the course at the time of follow up. Details 






If horses had gone into remission following the initial three-procedure course, they were 
eligible for an additional procedure should signs return. Of these eligible horses, 26 
underwent a fourth procedure, 11 underwent a fifth procedure and 4 underwent a sixth 
procedure. 
The median interval between the first and second procedures was 6 days (range 3–36 days) 
due to long remission from the first procedure, n = 133, interval not recorded in 32 horses, 
three horses did not continue to a second procedure or had not done so by the time of 
follow-up (Table 1) and the second and third was 14 days (range 4–165 days) due to long 
remission from the second procedure, n = 125, interval not recorded in 31 horses, 9 horses 
did not continue to a third procedure or had not done so by the time of follow-up (Table 1). 
Table 1: Details of numbers of cases undergoing initial three procedure course. 
Complications 
Complications were reported in 47/530 procedures (8.8%, Table 2). In all but one case, 
complications were transient. Of these, worsening of signs presumed to be secondary to 
neuritis was the most frequent complication occurring in 18/530 (3.4% procedures). No self-
trauma was reported. All but one horse’s signs returned at least to pre-treatment baseline in 
a few days and this occurred more rapidly if dexamethasone was administered intravenously 
at 0.1 mg/kg. One horse, treated soon after the onset of headshaking, showed a worsening 
of signs after each of two procedures. The horse’s compliance was also poor, so it was 
decided not to perform the third procedure and that horse’s clinical signs continued to 
progress. It is unclear whether this progression was a direct result of the neuromodulatory 
therapy, or the natural disease course in this horse. Suspected neuritis was reported more 
than once over the treatment course in four cases, which accounted for 9/18 (50%) of 
episodes. This was reported on two occasions in three cases; in one case with the first and 
third procedures and in the others with the first and second. One of these is the horse 
detailed above which had also complied poorly with the procedures, so a third procedure 
was not attempted. In the other case, dexamethasone was given prior to the third procedure 





















at time of 
follow up 
Unknown 
1 168       
2 165   2  1  






and no subsequent neuritis was observed. Suspected neuritis occurred after all three 








Haematoma Dermatitis Catheter 
complication 
Colic 
1 7 2 6 4 3 1 
2 6 1 4 2 0 0 
3 5 0 5 0 0 0 
4 0 0 0 0 0 0 
5 0 0 1 0 0 0 
6 0 0 0 0 0 0 
Table 2: Complications recorded for each procedure. 
Success rates 
The proportion of horses going into remission following the initial three-procedure course 
was 53% (72/136) with follow-up data which includes two horses which remained in 
remission after two procedures and did not complete the third, 64/136 were non-responders, 
20/156 were lost to follow-up or could not be evaluated due to being out of work because of 
other conditions). The median duration of remission was 9.5 weeks (range 2 days to 156 
weeks and ongoing). This calculation of the duration of remission included not only the 
length of time until signs returned (36/72, 50%) but also the time to follow-up for those still in 
remission at the end of the study (33/72, 46%). There was a small number of horses (3/72, 
4%) which, having gone into remission were then out of work for reasons other than 
headshaking. For these horses, the duration of remission was taken to be until the last date 
the horses could be assessed i.e. when still in ridden work. Figure 5 displays how remission 
was sustained over time. At 56 weeks following the third procedure, 15% of cases remained 
in remission and these then remained in on-going remission at the last follow up at 156 







Figure 5: Kaplan-Meier survival plot demonstrating the proportion of horses entering 
remission at the end of the initial three-procedure course and the maintenance of remission 
over time. The dotted lines are 95% confidence intervals. 
Within the initial three-procedure course, 35% (46/130) of horses went into remission after 
the first procedure (84/130 not in remission, 38/168 not recorded) with a median length of 
remission of 3 days (range, 1–14 days) before relapsing prior to the second procedure. 
Following the second procedure, 43% (60/137) of horses went into remission (77/137 not in 
remission, 28/165 not recorded) before relapsing prior to the third procedure. The median 











 Status at time of follow-up of horses which went into remission 







Out of work for 
another reason 
2 2 0 0 
3 30 35 2 
4 7 9 1 
5 3 5 0 
6 2 0 0 
Table 3: Status at time of follow-up of horses which went into remission after each 
procedure. 
A Cox proportional hazards regression model was performed to assess for significant 
predictors of remission after the initial three-procedure course. Nerve blocks, centre and 
seasonality were all non-significant (P>=0.15) and are displayed in Table 4. However, 
horses were significantly (P<0.001) more likely to go into remission at the end of the first 
three-procedure course if they went into remission after the first procedure and second 



















































1.906e+00 6.724e+00 1.139e+00   1.673 0.09 
Nosenet – 
no response 




-1.551e+00 2.121e-01 1.183e+00 -1.311 0.19 
Nosenet – 
worse signs 
-1.423e+00 2.409e-01 1.219e+00 -1.167 0.24 
Seasonal 
signs 
-8.198e-02 9.213e-01 5.636e-01 -0.145 0.88 
Seasonality 
unknown 
-7.643e-02   9.264e-01 3.500e-01 -0.218 0.83 
Centre 2 -8.944e-01   4.088e-01  1.047e+00 - 0.854 0.39 
Centre 3 8.620e-01   2.368e+00   8.560e-01 1.007 0.31 
Centre 4 -4.572e-03 9.954e-01   5.147e-01 - 0.009 0.99 
Centre 5 1.323e-01   1.141e+00   6.398e-01 0.207 0.84 
Centre 6 7.549e-02 1.078e+00 1.043e+00 0.072 0.94 
Centre 7 NA      NA 0.000e+00      NA NA 
Centre 8 NA NA 0.000e+00      NA NA 
Centre 9 2.912e-01   1.338e+00   6.403e-01   0.455 0.65 
Centre 10 1.007e-01   1.106e+00   1.062e+00 0.095 0.92 
Centre 11 -1.023e+00   3.596e-01   7.896e-01 -1.295 0.19 
Centre 12 1.142e+00   3.132e+00   7.822e-01   1.460 0.14 
Centre 13 2.298e-01   1.258e+00   6.207e-01   0.370 0.71 
Table 4: Results of Cox proportional hazards regression model for predictors from history on 






There were 26 horses which, following recurrence after remission from the initial course, 
received a fourth procedure. Of these initial responders, 69% (18/26) went back into 
remission. There were 32% of horses still in remission 12 weeks after the fourth procedure 
and these remained in on-going remission with up to 140 weeks’ follow-up. 
There were 11 horses which received a fifth procedure. Of these, 82% (9/11) went back into 
remission. There were 30% of these horses still in remission 14 weeks after the fifth 
procedure and these horses remained in on-going remission with up to 140 weeks’ follow-
up. Figure 6 demonstrates the proportion of horses in remission after the last procedure they 
received and the maintenance of remission over time. There were four horses which went on 
to have a sixth procedure following recurrence of signs after a fifth procedure. Two went 
back into remission, which was ongoing at 28 and 56 weeks after this sixth procedure. 
 
Figure 6: Kaplan-Meier survival plot demonstrating the proportion of horses entering 
remission after their last procedure and the maintenance of remission over time. 









This study demonstrates that EquiPENSTM neuromodulation can be an effective and safe 
treatment for the management of trigeminal-mediated headshaking in some horses. The 
data suggest that approximately 50% of cases will respond to the initial three-procedure 
course. Crucial, however, is whether remission is sustained and if not, how long until signs 
can be expected to recur and whether further treatment will result in remission again. Our 
results suggest that should a horse remain in remission for longer than 56 weeks from the 
initial course, the remission might last for years. However, for most horses, it can be 
expected that remission will be shorter. The median length of remission was 9.5 weeks. 
However, it should be noted that almost half of the cases were still in remission at the time of 
follow-up, so a longer study would be likely to show a longer median remission time. When 
signs recur, most but not all, horses can be expected to return to remission following 
additional procedures. This return to remission was usually but not always, longer-lasting 
than from after the previous procedure. 
There was wide individual variation in how horses responded and no predictors of response 
were identified. Whilst horses were more likely to go into remission at the end of the initial 
three-procedure course if they had gone into remission following the first and second 
procedures, this was not exclusively the case. The only way to know if a horse will respond 
is to attempt treatment. Where horses responded to the initial course it was not possible to 
predict length of remission. Although most horses which responded but then relapsed did 
respond again to additional procedures, this was not the case for all. Even in a successful 
case, this uncertainty would impact on a horse’s re-sale value. 
The numbers of horses going into remission increased with each subsequent treatment 
within the initial course. Horses were more likely to go into remission at the end of the course 
if they had responded during the course. This suggests a minimum of three procedures 
should be undertaken. There may be benefit in continuing to pursue treatment in horses 
which have not responded to the third procedure, but with reducing odds of success. It is, 
therefore, the authors’ recommendation that the protocol of performing an initial three-
procedure course be continued with a fourth procedure only being offered to responders 
which have then relapsed. 
A further advantage of EquiPENSTM is the short competition detection time for 
pharmaceuticals used during the procedure, namely sedation and local anaesthetic. This 
allowed several horses in this study to compete at a high level whilst their clinical signs were 






Studies of headshaking are at risk of a placebo effect and false positive results due to 
spontaneous remission. There are two studies on headshaking treatments which were 
designed in such a way as to be able to quantify the placebo effect on owners of treatments 
for this condition [12,13]. The study by Pickles et al. [12] investigated an effect of a 
gonadotrophin-releasing hormone vaccine in trigeminal-mediated headshakers. One-third of 
owners reported a subjective improvement in headshaking signs, but no real improvement 
was detected when considering results of serial scoring of signs on a visual analogue scale 
made by the same owners. The study by Talbot et al. [13] was a double-blinded placebo-
controlled trial of a commercially available feed supplement for headshaking. Videos taken at 
set time-points within the study were assessed by veterinary surgeons with no significant 
difference found across the study, contrasting with the owners’ positive subjective 
impression of effect on headshaking signs of both the supplement and the placebo. Ideally, 
our study would have included a placebo or control group. The data from our study suggests 
that for a control to be valid, the horse should be monitored for clinical signs for 1 year. 
During this year, no other treatments could be administered and the horse not euthanased. It 
would not be ethical to enrol horses into this study to leave them without treatment for a 
painful condition. A sham treatment course could be used, inserting the probes under 
sedation but not performing electrical stimulation. The sham treatment would have to be 
performed first and the real treatment 6 weeks later. Government ethical approval would 
have to be obtained for this study and it would be unlikely to be obtained, given the 
considerable time-period where no other treatment could be administered if horses were 
showing clinical signs of pain. The results of this study, relying on owner reports at follow-up, 
must be considered in the light of a lack of a placebo or control group. However, steps were 
taken in study design to reduce a placebo effect. All horses were showing clinical signs at 
the time of treatment. Remission was taken as return to ridden exercise at the previous level, 
in all but one case which was not yet in ridden work and so was assessed on the lunge, 
within 3 weeks of the last procedure. 
The practical nature of the definition given to remission was chosen as being less likely to 
result in a false positive result than the owners’ subjective interpretation of improvement in 
signs [12,13]. 
There is a risk of false positive results, with headshaking signs having resolved due to a 
change of season, or to spontaneous resolution of the condition. To reduce this risk, signs 
had to resolve within 3 weeks of the last procedure for that resolution to be attributed to the 
neuromodulation. There was no effect of seasonality on chances of, or length of, remission. 






differentiate from seasonal remission, is reported from an owner survey to occur in 5% of 
headshakers [3]. The median length of time for which horses were affected prior to 
presentation was 4 months, range 0.5-84 months. It would seem unlikely that the 50% of 
horses going into remission within 3 weeks of neuromodulation would all have recovered 
spontaneously. 
It is possible that some of the horses in this study were mis-diagnosed, which would 
confound results. The diagnosis of trigeminal-mediated headshaking is currently one of 
exclusion, making misdiagnosis more likely than for a condition where there is a specific test. 
Furthermore, the diagnoses were made by several different veterinary surgeons at different 
centres and in different countries. All centres were provided with guidelines for reaching a 
diagnosis. These guidelines had to accommodate some variation between centres, for 
example computed tomography of the head was not available at the time in all the countries. 
It may be possible in the future to further develop a technique measuring somatosensory 
evoked potentials as a definitive test for trigeminal nerve sensitisation, which alongside the 
guidelines issued to centres, would improve accuracy of diagnosis. 
Complication rates were low, and in all but one case, all side-effects were transient. This is 
of importance for a technique which must be repeated and has far from a guarantee of 
success. Where horses exhibited signs consistent with suspected neuritis, there was a 
strong tendency for these signs to occur again following the next procedure. In these cases, 
there may be some merit to considering administration of dexamethasone prior to the next 
procedure. This may reduce the risk of recurrence of suspected neuritis, although this is 
based on only one horse. There may also be merit to local administration of corticosteroid, 
although the authors have not trialled this yet. Even in horses where dexamethasone was 
not administered for suspected neuritis, signs did not result in self-trauma and resolved in a 
few days in all but one case, so the risk to benefit ratio of corticosteroid administration 
should be considered on an individual basis. 
Advances in treatment for trigeminal-mediated headshaking will remain limited until the 
aetiopathogenesis of the condition is understood. It is certainly possible that there is more 
than one cause with the same clinical manifestation, leading to different response rates to 
treatment. It is recognised in human medicine that response to treatment for neuropathic 
pain varies amongst individuals, even with the same diagnosis [14]. Therefore, even if all 
trigeminal-mediated headshakers have the same underlying condition, response to the same 
treatment may vary. Also, the mechanism of action of any neuromodulatory therapy is not 






neuromodulation in any species. The lack of knowledge in this area limits our ability to 
determine whether adaptations of the EquiPENSTM technique could lead to remission in non-
responders and longer remission times in responders. It also limits our ability to compare the 
technique to electroacupuncture [11], leaving the only way to make a comparison being to 
compare the use of a uniform electroacupuncture technique over a similar number of 
appropriately diagnosed horses. 
In conclusion, based on these results, we recommend that at present, EquiPENSTM 
neuromodulation be considered for the management of trigeminal-mediated headshaking in 
horses where a nose-net is unsuitable. Further advances in the understanding of the 
aetiopathogenesis of trigeminal-mediated headshaking are vital for there to be real progress 
in treating the condition. In the shorter term, a greater understanding of neuromodulation 
could aid refinement of the EquiPENSTM technique. 
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General discussion and options for future research 
7.1 General discussion 
This thesis draws together my original research work furthering the understanding of equine 
trigeminal-mediated headshaking. Alongside this is my own personal research journey. I 
have learned an enormous amount, starting with a small retrospective study and building up 
to a large, international, multi-centre prospective study. I have learned, amongst other 
things, about study design, grant writing, ethics, informed consent for enrolment, 
questionnaire use, operator bias, placebo effect, the need for and challenges of controls and 
placebo groups, working with collaborators, handling datasets, paper writing and supervising 
research students. I have learned that my future studies should be prospective, with control 
or sham groups where possible, to work with collaborators and use an objective measure of 
assessment where possible. I have a lot more to learn, in particular with regard to statistics 
and am very grateful to the support of Professor Mick Bailey for his work on this in Paper 
Six. This journey is one on which I intend to continue for the rest of my career. 
7.2 Research findings 
i. Prevalence (Paper One) 
This work provides evidence of the prevalence of owner-reported headshaking in the UK 
equine population (4.6 – 6.2%). This statistic will include horses with a range of causes for 
their headshaking, which would include head tossing from musculoskeletal pain. If a similar 
study was repeated, a more detailed description of what type of headshaking the horses had 
demonstrated could help identify the proportion of horses within that group which were likely 
to be showing signs consistent with neuropathic facial pain. Information on prevalence in 
other countries is required. Avoiding bias in an owner survey is very challenging. Efforts 
were made to avoid bias, by placing the headshaking specific questions within a general 
health questionnaire to avoid a predominance of owners with an interest in headshaking. 
The horse owner population which answered the survey was deemed to be representative of 
a general population as their responses for laminitis correlated with those found in other 
studies. However, laminitis as headshaking, is a condition where owners may consult other 
owners or para-professionals rather than their veterinary surgeons. Very few owners in our 
study had sought veterinary attention for their horses. Of those, only one horse was reported 
by the owner to have been diagnosed with trigeminal-mediated headshaking. There may be 
a lack of owner understanding of their horse’s diagnosis however, as two horses had 






complete remission. A future study could be made more robust by asking for videos of the 
horse’s headshaking, although then this would reduce responses as this information would 
be limited to those horses currently showing signs and to very engaged owners. Asking for 
access to the veterinary records for affected cases would give more reliable data as to the 
nature of the headshaking, its investigation, diagnosis and treatment but would be limited to 
the small proportion of cases where veterinary attention had been sought. 
To avoid some of these challenges, it can be possible to consider data on horses seen by 
veterinary surgeons for headshaking. Determining the proportion of cases that are seen over 
a year’s time period for headshaking as opposed to other complaints would help to 
determine prevalence within a population where veterinary attention is sought. It would be 
necessary to compare numbers presented for headshaking against numbers presented for 
investigation of other suspected disease processes rather than those presented for routine 
care. However, our study revealed that many horses which headshake do not receive 
veterinary attention and so this proportion, likely to include mildly affected trigeminal-
mediated headshakers who respond to a nose-net, would not be detected. Furthermore, a 
diagnosis might not be reached by a first-opinion veterinary surgeon and indeed, diagnosis 
of trigeminal-mediated headshaking should ideally include advanced imaging and referral to 
a hospital so some information would remain missing. 
The proportion of horses presenting to hospitals for investigation for headshaking could be 
compared to that if the general population for that hospital. Whilst this is useful data, it 
biases results towards a referred population. Some hospitals would see a biased proportion 
of cases due to being particular centres of excellence for the condition so several hospitals 
would have to be enrolled in the study. 
A study from 1987, before advanced imaging was used in equine practice, found that up to 
98% can be expected to receive a diagnosis of trigeminal-mediated headshaking (Lane and 
Mair, 1987). This study could be repeated, with the proportion now likely to be lower, at 90% 
(unpublished data).  
Prevalence constitutes one aspect of impact. The impact of a condition is considered when 
prioritising research and so is vital to establish.  
7.2.ii Aetipathogenesis (Paper Two) 
This research found no evidence of trigeminal nerve root demyelination in a limited number 
of horses affected by trigeminal-mediated headshaking. Many sufferers of human trigeminal 






trigeminal-mediated headshaking. This implies that translational research may be more 
applicable to managing the clinical condition and to seeking an alternative 
aetiopathogenesis. 
There are, however, a number of improvements to this study which could be made in future 
studies. The controls could be horses with a known history, euthanased for reasons other 
than headshaking, rather than an unknown abattoir sample. The entirety of the nerve should 
be studied, and also the brainstem, whereas this study sectioned nerves from brainstem to 
parallel with the 6th cheek tooth. The nerve can be frozen immediately on removal, prior to 
sectioning to give better samples than our obtained by formalin-fixing. Further stains, mostly 
heavy metal staining and using thicker sections can be better for a more thorough 
examination of long axons. Special stains used for investigation of axonopathies can include 
Bielschowsky silver impregnation and de Olmos amino cupric silver. There are genetic 
axonpathies in people where there is a lowered threshold potential. Histological comparison 
would be interesting, although all nerves are affected in these individuals, from birth. 
Pathologists should be blinded and independent in their assessment of slides, whereas in 
our study they were not blinded and reviewed the slides independently but then reached 
agreement together. They focussed on demyelination and then a more general assessment 
of whether there was any structural change to the nerve. Establishing pre-defined criteria to 
consider, such as reviewing slides for evidence of Renaut bodies which can occur at sites of 
nerve impingement would make the examination of slides more robust.  
The apparent structural normality of the nerve may be a positive finding as a functional 
rather than structural abnormality holds potential to be reversible. The potential for the 
condition to be reversible is supported by several clinical factors. These include that many 
cases may show seasonal remission and there is a likely 5% spontaneous remission rate. A 
condition which is reversible may be more amenable to treatment and it opened the option of 
trying management through neuromodulation. 
7.2.iii Diagnosis (Paper Three) 
This paper clarified which nerve branches are likely affected when local anaesthetic is 
deposited near the round foramen. A strong influence of experience on accuracy of the 
technique was documented, which therefore affects interpretation of the result. The work 
could be expanded to better consider the clinical application of the technique. In clinical 
practice, the volume of local anaesthetic solution is several times greater than the volume of 
contrast medium used in the study. Expanding the study to observe the deposition pattern of 






This should be imaged at various time points after the injection to mimic the use of 
diagnostic local anaesthesia in a clinical situation and follow likely diffusion patterns for the 
solution. Trigeminal-mediated headshaking is currently diagnosed by exclusion and any 
work which refines this process is beneficial. 
7.2.iv Treatment (Papers Four, Five, Six and Seven) 
The first two of these papers demonstrated a treatment which could have fair results but 
proved to have a high risk of very serious complications. Papers six and seven document the 
development of a neuromodulatory treatment with improved success rates and far lower 
complications and severity of those complications. Whilst it is progress to be able to offer this 
neuromodulatory treatment, we are still far from finding a cure for most cases. 
Considering papers four and five, there are a number of improvements which could be made 
to the studies, beyond those considered in the discussion sections of those papers. There is 
one horse in Paper Four which was treated only unilaterally due to unilateral signs. Now that 
more is known about the condition, I would consider this horse to have been mis-diagnosed. 
Had CT been available at that time, we may have been able to make a different diagnosis. 
This highlights the challenge where a diagnosis is made by exclusion. The complication of 
self-trauma from the surgery reported in Papers Four and Five is a major concern. Although 
management of these complications was reported, efficacy of this medication was not and 
would be required to inform any future use of the procedure. The possibility of recording 
whether or not coil migration was involved in surgical success or failure was considered but 
not performed and this would also improve our understanding and potentially allow 
refinement of the technique. 
Considering Papers Five and Six, it was not discussed why the site for neuromodulation was 
selected to be at the infra-orbital formen when the response to diagnostic local anaesthesia 
is much better when performed further caudally. The reasoning was ability and safety of 
access. However, use of radio-frequency ablation at the sphenopalatine ganglion is 
considered in the next section with options for future research. In Paper Six, there were 
multiple centres and veterinary surgeons involved. Although all were trained and given 
guidelines to follow when making a diagnosis of trigeminal-mediated headshaking, this 
inevitably increases the variables and risk of mis-diagnosis in a condition where diagnosis is 
by exclusion. If diagnostic local anaesthesia was more reliable then this could be a required 
step. Certainly, it would have been possible to require having had CT scan in order to be 
included in the study but this would have limited numbers. The possibility of developing the 






section on future options for research and if possible to perform, could further refine 
diagnostics and case-selection for treatment. Ideally, horses would be enrolled onto a study 
where a blinded sham course of treatment could be performed initially. This, however, is 
unlikely to be possible practically as it carries welfare implications and would need Home 
Office licensing. Furthermore, a delay in providing treatment to allow sham treatments to be 
performed and evaluated could risk confusing response to treatment with a natural seasonal 
remission in some horses. It would also reduce numbers of owners willing to enrol in the 
study due to extra inconvenience and expense. However, the possibility of including a 
control or sham group must be considered when planning studies into headshaking 
treatment. 
In Paper Four, follow-up information was obtained mostly from the owner but on some 
occasions from the referring veterinary surgeon. It was not recorded which method of follow-
up was obtained for each case. It would be of particular interest to obtain follow-up by both 
methods for each horse and then compare the owner’s report of the horse’s response with 
that of their vet as this may reveal incidences of placebo effect. There was a short median 
follow-up time, with the shortest cases excluded. A long follow-up time is particularly 
important where clinical signs may be shown seasonally. The later papers considering 
treatment all used owner reports for follow-up. This could be improved by asking referring 
veterinary surgeons for their reports also, viewing videos and competition results where 
possible. Another improvement would be asking owners if they would opt to repeat the 
treatment if they were to own another horse with the same condition, as a measure of owner 
satisfaction. Ultimately, the best way to improve the quality and reliability of feedback will be 
to develop an objective measure of headshaking, which we hope to do using an 
accelerometer.  
7.3 Future options for research 
There is very little known about trigeminal-mediated headshaking. Further research is vital, 
with greater understanding of the condition being key to improving its treatment and 
potentially, to preventing it. Further research is required in all the areas covered by this 
thesis; impact, aetiopathogenesis, diagnosis and treatment. 
The priority given to research into trigeminal-mediated headshaking should be influenced by 
the impact of the condition. This thesis covers some work into prevalence, which forms just 
one part of the impact of a condition. While figures on wastage to the equine industry due to 
trigeminal-mediated headshaking can be estimated, a true population calculation is 






whose clinical signs are manageable, those which are manageable only if retired, those 
euthanased as they cannot be used, and those euthanased on welfare grounds should be 
the aim. Additionally, these statistics, and those for prevalence, should be determined in 
countries other than the UK. There seems to likely be a complex environmental role in the 
aetiopathogenesis of trigeminal-mediated headshaking and this requires research. 
Determination of prevalence in countries with different climates and different management 
practices and comparison with already established data may add to understanding of 
aetiopathogenesis and indeed to understanding of impact. Anecdotally, prevalence in the UK 
is increasing. This may be due to greater awareness of the condition and indeed, an 
acceptance that headshaking may occur due to a medical condition. Comparison of 
prevalence in the UK over time may reveal if this is the case and if so, why it is the case. 
The key to treating and potentially preventing, this condition, will be to understand the 
pathophysiology and how, and why, it occurs. Given that there are no changes at a 
microscopic level in the nerves a functional disorder is presumed, therefore research at cell 
physiology level, such as ion channel function, should be considered. This could focus on 
axonal transport initially, given that there may be reduction of clinical signs with magnesium 
and boron supplementation (boron given to enhance magnesium uptake). There are specific 
axonopathies in people where threshold potential is reduced but these affect all nerves 
rather than seemingly, one branch of one cranial nerve. However, potential parallels could 
be explored by investigating ion channel function. 
It seems likely that there is a complex role of environment in the development of this 
acquired condition. Determining more information as to local climate, pollen types, diet and 
management practices may reveal a pattern although would be challenging when there are 
so many variables. It is not unusual for signs to be relived in a new environment, although 
often temporarily or for signs to resolve temporarily whilst competing (personal observation) 
which could be a short-term local environmental effect and perhaps interaction with 
neurotransmitters such as adrenaline. Further work here could help uncover underlying 
interactions. There must also be a role of individual susceptibility. The author is currently 
exploring the possibilities of comparing RNA expression of axon channel genes, to compare 
affected with unaffected horses. This work is in its early stages but is in collaboration with 
the University of Bristol Genomics facility and the Avon Longitudinal Study of Parents and 
Children (ALSPAC, ‘Children of the 90s’) who bring extensive experience and knowledge. 
There are also some horses seasonally affected, some not so. It should be determined 






have different conditions with similar clinical signs. This would be possible to determine once 
aetiopathogenesis is determined in either seasonal or non-seasonal groups. 
Once aetiopathogenesis has been determined, this would open options not just for treatment 
but for diagnosis. A diagnosis of exclusion as it is currently, carries limitations. However, 
there is potential to improve diagnostic sensitivity and specificity should more data determine 
whether a reduced threshold potential is a consistent finding for all horses with trigeminal-
mediated headshaking. If this is confirmed to be the case, exploring whether the procedure 
can be tolerated or modified to allow performing under standing sedation, and whether such 
measurements remain accurate, is required. At present it has only been performed under 
general anaesthesia which presents a patient risk, and a cost, both of which could be 
reduced if it could be performed under standing sedation, making this an achievable gold 
standard for diagnosis in a clinical setting. 
The lack of an objective measure of headshaking is a consistent challenge to determining 
efficacy of treatment. The author is currently exploring validation of an accelerometer device 
to give an objective measure. 
Consideration must be also be given in any study of treatment as to whether a control and/or 
placebo group is possible. It should be aimed for but may not be possible as usually welfare 
would be compromised.  
The early work published on electroacupuncture is promising in that it may provide a more 
accessible treatment with similarities to neuromodulation. However, the published study on 
electroacupuncture is on a small number of horses and reports results poorer than the first 
small study on neuromodulation (Paper Five). A larger study of electroacupuncture is 
required to make a comparison to the results of neuromodulation. A blinded study comparing 
the two techniques or with a sham or control group would be ideal. As for Paper Six, the 
same challenges exist in reaching as reliable a veterinary diagnosis as possible, needing 
multiple centres to give numbers but then increasing variables, using the same equipment 
and protocols, and the challenges of follow-up.  
Further work into neuromodulation in any species may increase our understanding of how it 
works, allowing refinement of the technique. There is potential to explore the use of an 
implant to facilitate repeated neuromodulation in cases with a short remission time and there 
has been some success in unpublished cases (personal communication, Dr. K. Pickles). 
Recent changes in rules for some equestrian competitions mean that it may be possible to 






change enables further work to be done with implants with a potentially practical outcome. 
Further translational work into treatment of neuropathic pain in any species may be useful. 
The author is exploring the possibility of radio-frequency stimulation of the sphenopalatine 
ganglion of the trigeminal nerve. Ganglia are aggregations of nerve cell bodies outside the 
central nervous system. Thus, specifically targeting this area could result in a more effective 
treatment for neuropathic pain.  
The sphenopalatine ganglion has been targeted in human neuropathic pain patients, using 
radiofrequency. Pulsed radiofrequency of the sphenopalatine ganglion (SPG-PRF) in 
patients with chronic head and face pain of various aetiologies has been reported to give 
complete pain relief in 21% of patients and partial relief in 65% of patients (Bayer et al, 
2005). Twenty percent of these required repeat treatment within a four to 52 month follow-up 
period. No side effects were reported. In patients with refractory cluster headaches treated 
with SPG-PRF (Fang, et al, 2015), 11/13 episodic cluster patients and 1/3 chronic cluster 
headache patients were completely relieved of pain an average of 6 days after treatment 
(range 1-20 days). Only one patient suffered a relapse during the study period (mean 17 
months, range 12-30 months). Remission time between episodes was increased from an 
average of 8.7 months (range 5.8 – 11.6 months) to 16.6 months (range 11 – 21.6 months). 
One patient was treated with SPG-PRF again following return of pain at 9 months and this 
again induced remission for a further 11 months. Remission from a third procedure was on-
going at the time of publication. Since no side effects were reported, this study shows that 
the procedure can be repeated safely and can give repeatable remission.  
Radiofrequency has similarities to PENS neuromodulation in that it uses an electrically 
conductive probe with a current which alternates between frequencies. Whereas the PENS 
probe is wholly conductive and placed over the nerve bundle, with SPG-RF the tip of the 
probe only is conductive. It is placed into the SPG under intra-operative guidance of 
computed tomography or radiography. Heat is produced around the electrode tip. The 
exposure has a biological effect with induction of early gene expression demonstrated in the 
dorsal horn in cell culture studies (Sluijter et al, 1998). Permanent damage to the ganglion is 
not expected, unlike if continuous radiofrequency is employed. In animal studies of the 
sciatic nerve, oedema, cell and myelin pathology changes were not significantly different 
between sham and pulsed radiofrequency, but significantly different with continuous 
radiofrequency (Vatansever et al, 2008). Our study has so far identified the location of the 
sphenopalatine ganglion in the horse and external landmarks. We have obtained magnetic 
resonance images and CT images of the head and determined likely location of the 






To conclude there is an enormous amount of research still required in the field of trigeminal-
mediated headshaking. Whilst determining aetiopathogenesis is expected to bring a break-
through in management, it is likely that, as with human neuropathic pain, even with the same 
underlying condition, different individuals experiencing neuropathic pain may respond to 
different treatments. Finally, once the condition is better understood, research towards 
prevention would be the goal. 
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Guidelines issued to centres for diagnosis.  
Horses should have been diagnosed with trigeminal-mediated headshaking. 
i. Gold standard: The gold standard for this is likely to be proof that the trigeminal 
nerve is sensitised, obtained by performing somatosensory-evoked potentials. 
However, these must be performed under general anaesthesia. 
ii. History, signalment, observation: History, signalment and observation are 
likely to give you your index of suspicion for trigeminal-mediated headshaking.  
Headshaking is often acute in onset although some cases will be insidious in 
onset. Onset typically occurs between the ages of 5 and 12 years. About one 
quarter of trigeminal-mediated headshakers will improve when wearing a nose-
net, so improvement with a nose-net is consistent with trigeminal-mediated 
headshaking, although a failure to improve with a nose-net does not rule out this 
diagnosis. I would not expect trigeminal-mediated headshakers to respond to 
administration of phenylbutazone or systemic or inhaled corticosteroids. They 
might respond to medication such as carbemazapine or gabapentin. 
Headshaking is usually predominantly vertical and often accompanied by sharp, 
vertical twitches. There are usually signs of nasal irritation, such as snorting, 
rubbing the nose on surfaces or legs and sometimes striking at the nose. Signs 
may be seen at rest in the stable and or field but are usually worse at exercise. 
Although they may be worse when ridden than on the lunge, signs would usually 
be seen at exercise without a rider. About one third of cases are seasonally 
affected, and if so these are usually Spring/Summer affected. Some horses will 
show signs when outside, but not inside, on the same day.   
iii. Are signs of headshaking due to facial pain? If possible, demonstrate that the 
horse is headshaking due to facial pain. This would be demonstrated if the horse 
shows a positive response to diagnostic local anaesthesia of the trigeminal nerve. 
Only two sections of this nerve are practically accessible for infiltration of local 
anaesthetic. The most rostral part of the infraorbital nerve may be anaesthetised, 
which is best accessed as far caudally as possible as it emerges at the 
infraorbital foramen. It is relatively simple to perform but there is evidence to 
suggest that response is usually poor. The poor response may be that only a 
small portion of the nerve is affected by the local anaesthetic in this position. 






Innervation to the nasal mucosa is from the caudal nasal nerve, a branch of the 
infraorbital nerve which runs parallel to this nerve before branching in the caudal 
nasal foramen, usually caudal to the rostral aspect of teeth 109/209. Infiltration of 
local anaesthetic at the infraorbital foramen would not involve the caudal nasal 
branch and involvement of this branch may be important. It is perhaps because of 
this that results from diagnostic local anaesthesia of the caudal portion of the 
infraorbital nerve, before it enters the infraorbital canal, are better. A positive 
response to diagnostic local anaesthesia of the infraorbital nerve would be 
consistent with headshaking due to facial pain, although a negative result would 
not refute it as there are many limitations to the technique.  
iv. Is there gross pathology which could be responsible for causing facial 
pain? The next stage is to look for any gross pathology which could be 
responsible for the facial pain. Where an abnormality is found, it could be treated 
and then the horse observed to see if signs of headshaking are resolved, as 
abnormalities may be incidental. I perform upper respiratory tract and guttural 
pouch endoscopy, oral examination, basic ophthalmic examination. Where 
possible, computed tomography of the head should be performed and, if not, 
radiographs of the head performed.   
v. Grade the severity of headshaking. This may be graded as:  0/3 = no 
headshaking; 1/3 = headshaking at exercise but insufficiently severe as to 
interfere with ridden exercise;  2/3 = headshaking at exercise, of a severity 
sufficient to make riding impossible or dangerous; 3/3 = headshaking even at 
rest, in the stable and/or field. Please contact me to discuss suitability for 








Data collected from owners at follow-up.  















Suspension of powdered Sarracenia purpurea (Sarapin2) 
injected subcutaneously at the infra-orbital foramina 
1 
Cellulose based nostril powder spray ‘Nostril Vet3’ 3 




Salt supplementation 2 
Feeding spirulina 1 
Feeding a low starch diet 1 
Taurine supplementation 1 
Allergen immunotherapy 1 
Fly repellent 1 
Ceratohyoidectomy 1 
Extraction of the first pre-molars 1 
Extraction of a molar and supranummerary tooth 1 
Diastema treatment 1 
Medication of the temporomandibular joint with corticosteroid 3 
Medication of the nuchal bursa with corticosteroid 1 
Cranial therapy 2 
Acupuncture 6 
Laser treatment 1 
Ultrasound treatment 1 
Sinus lavage 1 
Riding in the dark 1 
Ear covers 3 
Riding in a headcollar 1 
Padding the poll under the bridle 1 
Application of magnets to the headcollar 2 
Bitless bridle 6 
‘Micklem’5 bridle 7 
Bucket nose muzzle 1 
 
 
  
 
